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ABSTRACT 
Voltage-gated potassium channels are primary determinants of cellular 
excitability in the mammalian nervous system. The localization of these channels to 
distinct cellular compartments influences components of neuronal function, including 
resting membrane potential, action potential characteristics and neurotransmitter release. 
Thus, understanding the mechanistic basis of ion channel localization can provide 
fundamental insight into human physiology. The overall goal of this dissertation was to 
elucidate the regulatory mechanisms governing localization and function of the Kv1.3 
voltage-gated potassium channel.    
 
The sympathetic branch of the autonomic nervous system innervates many organ 
systems including the kidneys, heart and blood vessels and was used as a model to study 
endogenous Kv1.3. We found that postganglionic sympathetic neurons express Kv1.3 
and that the channel exhibits a striking pattern of localization to the Golgi apparatus in 
the soma of these cells. Kv1.3 ionic current was also isolated from the soma of these 
neurons, indicating the channel is a determinant of the electrophysiological properties of 
sympathetic neurons. In addition, the specific inhibition of Kv1.3 with margatoxin was 
found to depolarize neuronal resting membrane potential, decrease the latency to action 
potential firing and increase nicotinic agonist-induced neurotransmitter release. 
Collectively, these findings demonstrate that Kv1.3 influences the function of 
postganglionic sympathetic neurons and led to the hypothesis that regulating channel 
localization may be a mechanism for modulating the activity of these cells.   
 
 In this dissertation, we propose that the observed Golgi retention of Kv1.3 may be 
a trafficking-dependent mechanism of channel regulation. To test this hypothesis, we 
used HEK293 cells as our model system. Our data show that the degree of Kv1.3 Golgi 
localization is inversely correlated with the amount of channel at the plasma membrane. 
In addition, the amplitude of Kv1.3 ionic current measured in cells with low Kv1.3 Golgi 
localization was significantly greater than the current measured in cells with high Kv1.3 
Golgi localization. One mechanism for localizing ion channels to the Golgi apparatus 
involves the Class I PDZ-binding motif (X-S/T-X-Φ). Deletion of the C-terminal PDZ-
binding motif of Kv1.3 decreased the intracellular Golgi localization of the channel and 
increased channel localization at the cell surface. Disrupting this canonical binding motif 
also increased the amplitude of Kv1.3 ionic current. These findings indicate that 
regulated subcellular distribution of the channel may be a determinant of Kv1.3 surface 
expression and function.   
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CHAPTER 1: COMPREHENSIVE LITERATURE REVIEW 
 
I. Introduction 
 
 
Ion channels are integral membrane proteins that mediate rapid changes in the 
electrical potential across cellular membranes (Katz and Miledi, 1970). These pore 
forming proteins open and close in response to specific stimuli and selectively allow the 
passage of ions through the lipid bilayer along their electrochemical gradient (Mullins, 
1975). Consequently, ion channels are major determinants of cellular excitability (Schauf 
and Bullock, 1979). In neurons, the complex spatial distribution of these proteins to 
specific subcellular compartments such as the soma, axons, dendrites and presynaptic 
terminals influences neuronal excitability and synaptic transmission (Chiu and Ritchie, 
1981; Rasband et al., 1998). Therefore, understanding the mechanisms governing ion 
channel localization can provide insight into neuronal function.  
This dissertation identifies the novel localization of the Kv1.3 voltage-gated 
potassium channel in sympathetic neurons of the autonomic nervous system. We propose 
that subcellular localization of Kv1.3 to the Golgi apparatus may be a mechanism of 
channel regulation. While trafficking-dependent mechanisms of regulation have been 
defined for other Kv1 family channels (Choi et al., 2005; Connors et al., 2008; Nesti et 
al., 2004; Watanabe et al., 2007; Zhu et al., 2003a), localization of Kv1.3 to the Golgi 
remains unexplored. One major mechanism for localizing ion channels to specific 
subcellular compartments involves protein-protein interactions (Gu et al., 2003; Kim et 
al., 1995; Manganas and Trimmer, 2004). The work presented here identifies a protein 
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interaction motif that contributes to the localization of Kv1.3 and shows that modulating 
this motif can alter channel function.  
The consequences of altering Kv1.3 channel function span a wide range of 
physiological processes, from immune responsiveness to olfaction (Beeton et al., 2006; 
Desir, 2005; Fadool et al., 2004; Rangaraju et al., 2009; Xu et al., 2003; Xu et al., 2004). 
This dissertation highlights the novel expression of Kv1.3 in postganglionic sympathetic 
neurons and suggests that modulating channel localization in this cell type may lead to 
changes in sympathetic excitability. Altering the distribution of Kv1.3 ion channels in 
these neurons may have significant effects on regulating sympathetic effectors, defining a 
new physiological role for this channel. Therefore, elucidating the critical role of ion 
channel localization is imperative to understanding the mechanistic basis of neuronal 
activity.    
 
II. Anatomy and Function of the Sympathetic Nervous System 
 
A. The Sympathetic Nervous System 
 
 
Chapter 2 of this study focuses on the expression, function and modulation of the 
Kv1.3 voltage-gated potassium channel, using the sympathetic division of the autonomic 
nervous system as a model system. The autonomic nervous system regulates homeostatic 
mechanisms, including gastrointestinal motility, reproduction, metabolic physiology and 
cardiovascular function (Bornstein et al., 2004; Ito and Scher, 1981; Jones et al., 1987). It 
is composed of three major subdivisions: sympathetic, parasympathetic and enteric 
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(Purves, 2001). In addition to providing tonic drive to target effectors, the sympathetic 
division of the autonomic nervous system also coordinates adaptive responses to stressful 
stimuli (Selye and Fortier, 1949; Purves, 2001) in an event commonly referred to as the 
fight or flight response. The sympathetic nervous system originates from brainstem nuclei 
and from the intermediolateral cell column of the spinal cord, where preganglionic 
sympathetic cell bodies extend from the thoracic (T1) to the upper lumbar (L2 or L3) 
segments (Purves, 2001).  Preganglionic sympathetic neurons innervate para- and 
prevertebral ganglia located outside of the central nervous system (CNS) (Purves, 2001).  
The paravertebral ganglia are situated bilaterally along the length of the vertebral column, 
while prevertebral ganglia are located midline and anterior to the vertebral column 
(Purves, 2001).  
Postganglionic sympathetic neurons (PSNs) are derived from the neural crest and 
contain cell bodies that reside in the para- and prevertebral ganglia (Le Douarin and 
Teillet, 1974).  PSNs extend long, generally unmyelinated, small diameter axonal 
processes outward to innervate various visceral effectors as seen in Figure 1 (Glebova 
and Ginty, 2005; Wallin and Charkoudian, 2007). The superior cervical ganglion (SCG) 
is a representative paravertebral ganglion composed of PSNs and has been used to study 
sympathetic activity (Li and Horn, 2006; Luther and Birren, 2006). In addition to 
providing sympathetic innervation to the eye, major target tissues for the SCG include the 
lacrimal, submandibular and parotid glands (Li and Horn, 2006). The SCG also provides 
sympathetic innervation to blood vessels (Cassaglia et al., 2008; Li and Horn, 2006). 
However, the sympathetic control of blood vessels is not well understood. The distal end 
of a postganglionic sympathetic axon is highly branched and contains a complex network 
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of small membranous swellings termed varicosities (Todd, 1980). These varicosities 
contain mitochondria and numerous large dense-core and small dense-core 
neurotransmitter containing vesicles (Devine and Simpson, 1968). They are known to be 
sites of local neurotransmitter release that greatly increase communication between 
sympathetic efferents and target vessels (Devine and Simpson, 1967, 1968; Jackson and 
Cunnane, 2001). 
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Figure 1: Anatomy of the sympathetic nervous system in a rodent model. Schematic 
representation of preganglionic (green) and postganglionic (blue) sympathetic innervation 
in a mouse. Preganglionic cell bodies are located in the intermediolateral (IML) cell 
column of the thoracic and lumbar spinal cord. Preganglionic fibers synapse onto 
postganglionic cells bodies in sympathetic ganglia (yellow). Paravertebral ganglia, such 
as the superior cervical ganglion (SCG), are situated bilaterally alongside the vertebral 
column. Postganglionic sympathetic fibers directly innervate target effectors such as the 
heart, kidney and blood vessels.  
 
Glebova et al. Growth and survival signals controlling sympathetic nervous system development. 
Annual Review of Neuroscience. (2005) 28, pp 191-222. 
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B. Sympathetic Neurotransmission 
 
Sympathetic ganglia from the adult mouse and rat are widely used as 
experimental models because they accurately reflect the sympathetic innervation of the 
vasculature in humans (Glebova and Ginty, 2005; Li and Horn, 2006). The experiments 
outlined in this dissertation will focus on the SCG.  Phenotypic characteristics such as 
neuropeptide content, electrical properties and morphology of these ganglia have been 
previously explored, making SCG neurons a powerful model system for studying 
sympathetic neurons (Anderson et al., 2001a; Anderson et al., 2001b; Gibbins et al., 
2000; Li and Horn, 2006; Morris et al., 1995). The experiments presented in Chapter 2 
will use PSNs from primary cultures of dissociated neonatal rat SCG. Dissociated cell 
cultures grown in vitro provide the opportunity to carry out a variety of experimental 
techniques in a specific population of cells that can be maintained in a tightly controlled 
environment.  
While preganglionic sympathetic neurons utilize acetylcholine (ACh) as their 
main neurotransmitter, postganglionic sympathetic neurons are primarily adrenergic, and 
utilize norepinephrine (NE) (Gibbins and Morris, 2006; Kanagy, 2005; Morales et al., 
1995), as well as various neurotransmitter peptides. NE is a catecholamine 
neurotransmitter that is synthesized from the amino acid tyrosine in a series of enzymatic 
steps (Kirshner, 1957). Tyrosine is converted to dihydroxyphenylalanine (L-DOPA) by 
tyrosine hydroxylase (Kirshner, 1957). L-DOPA is then decarboxylated to form the 
neurotransmitter dopamine via the enzyme DOPA decarboxylase (Kirshner, 1957). In the 
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final step of norepinephrine biosynthesis, dopamine-β-hydroxylase oxidizes dopamine to 
form NE (Kirshner, 1957). The rate limiting enzyme in norepinephrine synthesis is 
tyrosine hydroxylase (TH) and is used to confirm the presence of postganglionic 
sympathetic neurons (Anderson et al., 2001b). The research presented in this dissertation 
utilizes TH as a marker of postganglionic neurons. Although we focus on NE release as 
the main measure of sympathetic activity, it is important to note that additional 
neurotransmitters, such as neuropeptide Y and ATP, are coreleased in conjunction with 
NE (Msghina et al., 1998; Wahlestedt et al., 1992). The release of NE from sympathetic 
nerve terminals has previously been used to measure sympathetic nerve activity and 
alterations in the release and reuptake of NE may provide insight into the function of 
these cells (Kristufek et al., 1999; Msghina et al., 1998; Socci et al., 2003; Uhrenholt and 
Nedergaard, 2003).  
 
C. Electrophysiological Properties of Postganglionic Sympathetic Neurons 
 
As described above, postganglionic sympathetic neurons communicate with target 
effector organs via the release of neurotransmitters such as NE (Bennett et al., 2004; 
McLachlan, 2007). Therefore, the function of these neurons is essential for maintaining 
the sympathetic regulation to various tissues, including blood vessels. ACh released from 
preganglionic sympathetic neurons binds to ligand-gated nicotinic receptors located in the 
soma of PSNs, causing membrane depolarization of the cell to reach threshold, 
generating an action potential which is conducted along the length of the postganglionic 
sympathetic axon (Muscholl et al., 1973). When the action potential reaches a 
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sympathetic varicosity or synaptic terminal, voltage-gated calcium channels permit entry 
of extracellular calcium into the cell and activate the release of neurotransmitters 
(Muscholl et al., 1973). Therefore, knowledge of the electrophysiological properties of 
PSNs is crucial to understanding the function of the sympathetic nervous system. 
Postganglionic sympathetic neurons can be classified into three main categories 
based on their electrophysiological discharge properties upon stimulation with a 
depolarizing current: Phasic (Ph), tonic (T) and long afterhyperpolarizing (LAH) (Cassell 
et al., 1986; Jamieson et al., 2003; Keast et al., 1993; McLachlan and Meckler, 1989). 
Phasic neurons fire multiple bursts of action potentials transiently upon depolarization, 
whereas tonic neurons fire action potentials throughout the duration of a maintained 
depolarization (Cassell et al., 1986). LAH neurons discharge only once, due to the 
prolonged outward current that may last several seconds (McLachlan and Meckler, 
1989). These three electrophysiological classes of sympathetic neurons are predominantly 
localized to different populations of ganglia (Boyd et al., 1996; Keast et al., 1993). The 
paravertebral chain is home to primarily Ph neurons, while T neurons and LAH neurons 
reside mainly in the inferior mesenteric ganglion and celiac ganglion, respectively 
(Jamieson et al., 2003).  
As is true for all neurons, electrophysiological properties of sympathetic neurons 
are governed by the expression and localization of various ion channels within the cell 
membrane (Arnold, 2007; Choe, 2002; Kaczmarek, 2006; Lai and Jan, 2006; Roeper and 
Pongs, 1996). In particular, voltage-gated potassium channels (Kv) are fundamental 
determinants of neuronal excitability. Based upon their localization within the cell, Kv 
channels can have different effects on neuronal physiology and neurotransmitter release; 
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affecting depolarization properties if localized to the soma, or action potential 
propagation if distributed along the axon (Lai and Jan, 2006). This dissertation focuses on 
elucidating the role of the Kv1.3 ion channel in sympathetic neuronal activity, and 
emphasizes the importance of subcellular localization on channel function.  
 
III. The Kv1.3 Voltage-Gated Potassium Channel 
 
A. Kv1 Channel Structure 
 
Voltage-gated potassium channels (Kv) are expressed throughout the mammalian 
nervous system, where they play a central role in regulating neuronal excitability via the 
maintenance of resting membrane potential, integration of synaptic input, and regulation 
of action potential firing (Armstrong and Hille, 1998; Catterall, 1988; Choe, 2002; Lai 
and Jan, 2006). These highly conserved channels are grouped into twelve families 
denoted Kv1 through Kv12 (Gutman et al., 2003). The Kv1 family of voltage-gated 
potassium channels is known as the Shaker family (Jan et al., 1977). First identified in 
Drosophila melanogaster, genetic mutations in the Shaker locus result in flies that 
vigorously shake their legs under anesthesia due to abnormal neuronal activity (Jan et al., 
1977). The Shaker family consists of eight genes encoding distinct alpha subunit proteins, 
Kv1.1 through Kv1.8 (Gutman et al., 2005). These alpha subunits can also associate in a 
1:1 stoichiometry with auxiliary beta-subunits (Kvβ1-3), which can alter channel 
trafficking, gating and function (Heinemann et al., 1996; Rettig et al., 1994). Functional 
channels are formed when four Kv1 alpha subunits assemble as homotetramers of 
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uniform subunits or as heterotetramers with other members of the Kv1 family (Shen and 
Pfaffinger, 1995). Formation of heteromultimeric channels greatly enhances functional 
diversity through the modulation of current conduction, as well as fine tuning channel 
regulation through multiple channel trafficking pathways (Choe, 2002).   
Several conserved structural regions within Kv1 channels are important for 
regulating fundamental aspects of channel localization and function. These regions 
include the six transmembrane domains (Yi et al., 2001), the intracellular N-terminal 
tetramerization domain (Gu et al., 2003), the putative voltage sensor (Borjesson and 
Elinder, 2008) and the potassium ion specific pore loop (Manganas et al., 2001b; Zhu et 
al., 2005). Basic properties of Kv1 channel assembly, gating, selectivity and conductance 
are governed by these structural domains (Choe, 2002; Debanne, 2004; Dodson and 
Forsythe, 2004; Judge and Bever, 2006; Lai and Jan, 2006).  
The work presented in this dissertation focuses on a specific member of the 
Shaker family, Kv1.3. Each Kv1.3 alpha subunit is composed of six transmembrane 
spanning domains, termed S1-S6 (Figure 2) (Choe, 2002). The first four transmembrane 
helices enable the channel to sense and respond to changes in membrane potential 
(Grottesi et al., 2005). In particular, the positively charged S4 segment serves as the 
voltage sensor and detects changes in membrane potential, rendering the channel in an 
open or closed state (Grottesi et al., 2005). The positive charge of the voltage sensing 
domain is conferred by multiple basic arginine residues in the S4 helix (Borjesson and 
Elinder, 2008). Upon membrane depolarization, conformational changes in the S4 
domain lead to opening of the channel pore and the influx of potassium ions (Borjesson 
and Elinder, 2008; Grottesi et al., 2005).  Between segments S5 and S6 lies the selectivity 
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filter, containing the signature sequence Thr-Val-Gly-Tyr-Gly that is characteristic of the 
pore loop (Doyle et al., 1998). Stereochemical checkpoints ensure the specificity of 
potassium ion flow through the narrow pathway of the pore loop (Doyle et al., 1998).   
The transmembrane spanning helices of Kv1.3 are flanked by cytoplasmic termini 
containing protein interaction domains (Gu et al., 2003; Kosolapov et al., 2004). The 
intracellular N-terminal region immediately preceding the first transmembrane helix (S1) 
of Kv1.3 contains a stretch of approximately 130 amino acids that mediates the 
tetramerization of four alpha subunits to form a holochannel (Gu et al., 2003; Kosolapov 
et al., 2004). Accordingly, this region is referred to as the T1 tetramerization domain. In 
addition to promoting the proper assembly of hetero- and homotetramers (Shen and 
Pfaffinger, 1995), the T1 domain has also been shown to target Kv1.3 to the axonal 
region of neurons (Rivera et al., 2005), indicating a role for this domain in both the 
function and localization of Kv1 channels.  
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Figure 2: Voltage-gated potassium channel alpha subunit structure. The alpha 
subunit of Kv1 channels is composed of intracellular N- and C-termini and six 
transmembrane spanning domains (S1-S6). The N-terminus contains the T1 
tetramerization domain, S4 (+) is the voltage sensor, and the poor loop selectivity filter 
(P) lies between S5 and S6.  
 
Choe, S. Potassium Channel Structures. Nature Reviews Neuroscience. (2002) 3, pp 115-120. 
 
 
 
B. Physiological Significance of Kv1 Channels  
 
Voltage-gated potassium channels play a major role in regulating cellular 
excitability through the delicate control of potassium ion flow across the plasma 
membrane (Yi et al., 2001). These channels open and close in response to changes in 
membrane potential (Borjesson and Elinder, 2008) and facilitate events such as neuronal 
action potential propagation. Therefore, perturbations in Kv1 channel expression and 
localization could have significant consequences on neuronal function. Through the study 
of mutant channels and transgenic gene-targeted deletions, the biological importance of 
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Kv1 family channels has been well characterized (Brew et al., 2007; Lopantsev et al., 
2003; Tschritter et al., 2006).    
Point mutations in the Kv1.1 potassium channel gene (KCNA1) have been linked 
to a rare autosomal dominant disorder in humans. Known as episodic ataxia type 1 
(EA1), this channelopathy is characterized by intermittent episodes of unsteady gait, 
uncoordinated movements, and involuntary muscle twitches and is frequently associated 
with unprovoked epileptic seizures (Manganas et al., 2001a; Smart et al., 1998). Kv1.1-
null mice recapitulate these symptoms and also demonstrate increased brain growth and 
megencephaly (Persson et al., 2005; Petersson et al., 2003), predominantly in the 
hippocampus and ventral cortex (Almgren et al., 2007; Persson et al., 2007). 
Additionally, targeted deletion of KCNA1 in mice results in the hyperexcitability of CA3 
pyramidal cells, providing further evidence for high seizure susceptibility in these 
animals (Lopantsev et al., 2003).  Kv1.1 alpha subunits commonly co-assemble with 
Kv1.2 to form heteromultimeric tetramers in neurons (Brew et al., 2007; Wang et al., 
1994). These two Kv1 subtypes are often localized to juxtaparanodal regions in 
myelinated axons, where they contribute to regulating action potential propagation (Brew 
et al., 2007; Lai and Jan, 2006; Rasband and Shrager, 2000). Deletion of the gene that 
encodes for the Kv1.2 alpha subunit (KCNA2) also leads to spontaneous generalized 
seizures in mice (Brew et al., 2007), underscoring the importance of Kv1 channels in the 
maintenance of neuronal excitability.  
This dissertation focuses on Kv1.3, a Shaker family potassium channel closely 
related to Kv1.1 and Kv1.2. Although this channel exhibits limited expression in the 
central nervous system, high levels of Kv1.3 have been detected in brain regions such as 
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the dentate gyrus of the hippocampus, the hypothalamus and the olfactory bulb (Fadool 
and Levitan, 1998; Grosse et al., 2000; Veh et al., 1995). Also, Kv1.3 accounts for the 
largest proportion of outward current from olfactory bulb mitral cells (Fadool et al., 
2004). Gene-targeted deletion of this channel results in neurons with modified action 
potential characteristics; less current is required to elicit the same spike frequencies 
observed in wild-type cells (Fadool et al., 2004). In addition, behavioral assessments 
revealed that Kv1.3-null mice have a lower threshold for odor detection that is 
accompanied by increased odor discrimination, suggesting a link between neuronal 
excitability and behavior (Fadool et al., 2004). Conversely, recent studies indicate that a 
single-nucleotide polymorphism in the human Kv1.3 gene (KCNA3) results in a gain of 
function; accordingly, carriers of this polymorphism show impairments in olfactory 
function (Guthoff et al., 2009).    
Kv1.3 has also been highlighted as an important component of other physiological 
processes. Phenotypic examination of Kv1.3 deficient mice (Kv1.3 -/-) indicates that the 
channel is a determinant of body weight and energy homeostasis (Xu et al., 2003). In 
comparison to control littermates, Kv1.3 -/- mice display decreased body weight, 
increased metabolic rate and are resistant to diet-induced obesity (Xu et al., 2004). Kv1.3 
has also been found to contribute to the regulation of peripheral insulin sensitivity and 
glucose metabolism (Xu et al., 2004). Inhibiting Kv1.3 has been shown to decrease 
inflammatory cytokines, thereby increasing insulin sensitivity (Desir, 2005; Xu et al., 
2004). In addition, a polymorphism in the promoter region of human KCNA3 that alters 
transcriptional activity is associated with impaired glucose tolerance and reduced insulin 
sensitivity (Tschritter et al., 2006).  These findings also provide rationale to explore 
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Kv1.3 as a potential therapeutic target for metabolic diseases such as diabetes mellitus 
(Desir, 2005; Esler et al., 2001). 
Homotetrameric Kv1.3 channels are the major voltage-gated potassium channels 
expressed in T-lymphocytes, key mediators of autoimmune disease (Beeton et al., 2006; 
Panyi, 2005; Panyi et al., 2006; Panyi et al., 2004a). In these cells, the channel plays a 
central role in regulating resting membrane potential, Ca2+ signaling cascades, and 
antigen-dependent activation and proliferation (Lin et al., 1993). The expression of Kv1.3 
has been shown to dramatically increase when CD4+ and CD8+ T-lymphocytes are 
activated and inhibition of the channel suppresses downstream signaling cascades that 
lead to cell proliferation and cytokine production (Beeton et al., 2006). This research has 
placed Kv1.3 at the center of emerging therapeutic targets for T-cell mediated 
autoimmune diseases (Beeton et al., 2006).  
 
C. Kv1 Channel Pharmacology 
 
Because a plethora of diverse ion channels exist within cellular membranes, 
isolating current from voltage-gated potassium channels is a challenging task. However, 
pharmacological reagents that specifically block Kv channels have been used to resolve 
current from distinct channels (Garcia-Calvo et al., 1993; Kirpekar et al., 1977; 
MacKinnon and Yellen, 1990; Vacher et al., 2007). In addition, these pharmacological 
tools have been used to decipher the physiological role of differential channel localization 
(Panyi et al., 2006). Two main molecular pharmacological agents are capable of blocking 
or modulating Kv channels: organic compounds and venom-derived peptide toxins 
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(Grissmer et al., 1994; Gutman et al., 2005; Judge and Bever, 2006; Wei et al., 2005). 
These powerful probes have been used to investigate various Kv channel currents in a 
variety of cell types.  
 Most potassium channels possess the ability to pass ammonium ions, however the 
quaternary derivative, tetraethylammonium chloride (TEA), acts an open channel blocker 
of Kv channels (Cena et al., 1985; Crouzy et al., 2001; Heginbotham and MacKinnon, 
1992; MacKinnon and Yellen, 1990). While the effect of intracellular TEA is quite 
uniform in blocking Kv channels, the extracellular application of TEA is variable; Kv1 
channels demonstrate one of the lowest sensitivities to this organic compound, allowing 
the use of TEA as a tool to resolve currents produced by these channels (MacKinnon and 
Yellen, 1990). 
Another organic compound, 4-aminopyridine (4-AP), blocks a variety of Kv 
channels, having the greatest binding affinity for delayed rectifying channels of the Kv1 
family (Judge and Bever, 2006; Kirpekar et al., 1977; Msghina et al., 1998; Przywara et 
al., 1992; Thorneloe et al., 2001). This compound is known as an open channel blocker 
because upon application, the drug enters the pore region of an open channel, and 
becomes trapped within the intracellular face of the channel pore (Judge and Bever, 
2006). Researchers report that the addition of 4-AP to rabbit carotid arteries preloaded 
with [3H]-norepinephrine greatly enhances the stimulation-evoked overflow of NE, 
suggesting that voltage-gated potassium channel blockade increases neurotransmitter 
release from sympathetic neurons (Uhrenholt and Nedergaard, 2003). Studies of ocular 
hypertension in rabbits indicate that the topical application of 4-AP can elevate 
intraocular pressure (IOP) (Socci et al., 2003). Increases in IOP are accompanied by 
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increases in aqueous levels of NE (Socci et al., 2003). In isolated rabbit iris-ciliary body 
preparations, 4-AP causes a significant increase in field-stimulated NE release from 
sympathetic nerves (Socci et al., 2003). These experiments suggest that Kv channels in 
sympathetic nerves are important for regulating neurotransmitter release and provide a 
rationale for isolating specific Kv1 family currents from postganglionic sympathetic 
neurons. 
 Venom-derived peptide toxins are small, compact globular proteins that are 
highly potent Kv channel inhibitors selective for specific classes of ion channels (Judge 
and Bever, 2006). At low nanomolar concentrations, the snake-derived peptide toxin, 
dendrotoxin (DTX), can specifically inhibit Kv1.1 and Kv1.2 channels (Dodson et al., 
2003; Gasparini et al., 1998; Haghdoust et al., 2006; Harvey, 2001; Judge and Bever, 
2006). Similarly, the scorpion-derived peptide toxin, margatoxin (MgTx), can 
specifically inhibit Kv1.3 at low concentrations (Bednarek et al., 1994; Garcia-Calvo et 
al., 1993; Helms et al., 1997; Judge and Bever, 2006; Shah et al., 2003). While it is 
possible for some venom-derived toxins to incorporate into the lipid bilayer and modulate 
the voltage sensing region of potassium channels (Swartz and MacKinnon, 1995), DTX 
and MgTX exert their channel blockade in a different way. These toxins bind to the 
extracellular mouth of the pore region, blocking the flow of potassium ions through the 
channel  (Judge and Bever, 2006). The experiments outlined in this dissertation use both 
DTX and MgTX as pharmacological tools to specifically isolate endogenous 
Kv1.1/Kv1.2 and Kv1.3 currents, respectively. While venom-derived toxins used at 
specific concentrations are useful for blocking Kv1 currents, strong sequence homology 
of these channels may preclude toxin specificity in some instances. Therefore it is 
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important to note that additional molecular approaches such as RNA interference or 
transgenic knockouts may be needed to fully validate the scientific findings resulting 
from toxin blockade.   
 
D. Kv1.3 Regulation 
 
Voltage-gated potassium channels are subject to multiple mechanisms of 
regulation (Figure 3). Transcriptional regulation of Kv channels influences membrane 
excitability by up- or downregulating the amount of available channel protein within a 
given cell (Guthoff et al., 2009; Tschritter et al., 2006). Functional diversity is also 
regulated at various checkpoints within the biosynthetic pathway. At the level of 
translation, assembly of homo- or heterotetramers occurs in the ER and the ratio of 
subunit expression influences channel regulation (Kerr et al., 2001; Vicente et al., 2008). 
Primary amino acid motifs within the channel protein itself commonly control export 
from and retention in the ER (Li et al., 2000; Ma and Jan, 2002). Trafficking through the 
Golgi apparatus also serves as a locus for regulation; N-linked glycosylation of Kv1 
family channels in the Golgi is required for efficient plasma membrane expression 
Khanna et al., 2001; Zhu et al., 2001; Zhu et al., 2003).  Once in the plasma membrane, 
select ion channels undergo local trafficking events such as endocytosis and recycling 
(Nesti et al., 2004), shuttling them away from and back into the cell membrane. Many of 
these regulatory events are mediated by direct chemical modification of the protein, 
known as post-translational modification.  
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Figure 3: Voltage-gated potassium channel regulation. Kv1 channels are subject to 
multiple regulatory mechanisms, which occur in various cellular compartments such as 
the nucleus, endoplasmic reticulum (ER), Golgi apparatus, and plasma membrane.  
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Post-translational modification events play a key role in regulating the function of 
many voltage-gated ion channels (Catterall, 1988). Early studies reported that Kv1.3 
current was functionally regulated via manipulation of protein kinase A (PKA) and 
protein kinase C (PKC) (Cai and Douglass, 1993). These findings, coupled with evidence 
that Kv1.3 can be directly phosphorylated at specific sites, led to speculation that 
serine/threonine phosphorylation was the major mechanism of Kv1.3 regulation in cell 
types as diverse as T-lymphocytes and Xenopus oocytes (Attali et al., 1992; Payet and 
Dupuis, 1992). Studies involving other Kv1 channels also demonstrate that PKA and 
PKC alter single channel properties and current conductance, providing further evidence 
that serine/threonine phosphorylation plays a key role in Kv1 channel regulation (Huang 
et al., 1994; Tsai et al., 1997).     
In addition to extensive studies on serine/threonine phosphorylation of ion 
channels, the direct phosphorylation of tyrosine residues has also emerged as a key 
mechanism of channel regulation (Huang et al., 1993). In 1993, Huang et al found that 
the activity of Kv1.2 is modulated by tyrosine phosphorylation; m1 muscarinic 
acetylcholine receptor activation induced tyrosine phosphorylation of specific residues 
led to a suppression of Kv1.2 ionic current, without altering channel kinetics (Huang et 
al., 1993). Later studies determined that the mechanism of Kv1.2 current suppression was 
a physical removal of the channel from the plasma membrane known as endocytosis 
(Nesti et al., 2004). These findings were the first to link tyrosine phosphorylation 
dependent signaling to cellular excitability via the trafficking-dependent regulation of a 
voltage-gated potassium channel.   
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Following this seminal discovery, tyrosine phosphorylation of other ion channels 
has become an area of considerable interest (Holmes et al., 1996; MacFarlane and 
Sontheimer, 2000; Wang, 1999). Kv1.3 also contains multiple tyrosine residues that lie 
within potential consensus sites for tyrosine kinase-mediated phosphorylation (Figure 4). 
In 1996, Holmes et al published the first report of tyrosine phosphorylation modulating 
the functional properties of Kv1.3. This study showed that pharmacological inhibition of 
tyrosine phosphatase activity via pervanadate application, increased tyrosine 
phosphorylation of Kv1.3 in a dose-dependent manner (Holmes et al., 1996). This 
increase in Kv1.3 tyrosine phosphorylation was also accompanied by a concomitant 
suppression of Kv1.3 ionic current that was eliminated by introducing a single point 
mutation (Y449F) (Holmes et al., 1996).  These data provided the first evidence that 
direct phosphorylation of Kv1.3 is associated with functional suppression of ionic current 
(Holmes et al., 1996).    
Since the initial discovery that phosphorylation suppresses Kv1.3 current, both 
cellular and receptor tyrosine kinases have been found to alter the functional properties of 
Kv1.3 (Colley et al., 2004; Fadool et al., 1997; Marks and Fadool, 2007). Coexpression 
of Kv1.3 with the constitutively active nonreceptor tyrosine kinase, v-Src, suppresses 
channel current (Fadool et al., 1997). In addition, brain derived neurotrophic factor 
(BDNF)-induced activation of neurotrophin receptor tyrosine kinase B (TrkB) results in 
putative phosphorylation of multiple tyrosine residues on both the N- and C-terminus of 
Kv1.3 and is accompanied by suppression of current magnitude in rat olfactory bulb 
neurons (Colley et al., 2004). Similarly, insulin-induced neuromodulation of Kv1.3 
occurs through insulin receptor (IR) kinase activity at specific tyrosine residues (Marks 
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and Fadool, 2007). While several physiological stimuli suppress Kv1.3 ionic current in a 
tyrosine phosphorylation dependent manner (Colley et al., 2004; Fadool et al., 1997; 
Marks and Fadool, 2007), the exact mechanism of functional suppression remains largely 
unexplored.    
Major advancements in understanding the function and regulation of Kv1.3 were 
achieved by studying mice with a gene-targeted deletion of the channel (Biju et al., 2008; 
Fadool et al., 2004; Tucker et al., 2008). Along with post-translational modifications, 
protein-protein interactions have also been found to regulate Kv1.3 function (Fadool et 
al., 2004; Marks and Fadool, 2007). The expression of various modulatory kinases and 
scaffolding proteins normally associated with the channel was greatly altered in Kv1.3 
null mice (Fadool et al., 2004). In addition to both the cellular kinase, Src, and the 
receptor tyrosine kinase, TrkB, Kv1.3-null mice also exhibited upregulation of the 
synaptic adaptor protein, post-synaptic density 95 (PSD-95) (Fadool et al., 2004).  A 
recent study demonstrated that PSD-95 clusters Kv1.3 channels in specific membrane 
microdomains and significantly suppresses current magnitude of these channels via an 
activity-dependent mechanism (Marks and Fadool, 2007). These findings indicate a role 
for adaptor proteins in modulating the localization and function of voltage-gated 
potassium channels (Marks and Fadool, 2007).   
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Figure 4: The primary structure of Kv1.3 contains multiple regulatory motifs. The 
cytoplasmic N- and C-termini, as well as the poor loop region of Kv1.3, contain multiple 
tyrosine residues (•) that lie within consensus sequences for phosphorylation by Src 
kinase (*), TrkB (#), and insulin receptor kinase (+). In addition, Kv1.3 contains two 
proline rich domains (PXXP) which may bind SH3 domain containing proteins. The 
extreme C-terminus of Kv1.3 contains a consensus sequence (X-(S/T)-X-φ) known to 
bind PDZ domain containing proteins, such as the canonical PDZ protein, PSD-95.   
 
Colley et al. Brain-derived neurotrophic factor modulation of Kv1.3 channel is disregulated by 
adapter proteins Grb10 and nShc. BMC Neuroscience. (2009) 10:8. 
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IV. PDZ Domain Interactions 
 
A. Structural Basis of PDZ Domain Recognition 
 
Similar to many other ion channels, Kv1.3 contains a consensus sequence for the 
binding of PDZ domain containing proteins (Kim et al., 1995). Often arranged in tandem 
arrays or in conjunction with other interaction domains, PDZ domains are protein-protein 
recognition modules that can assemble large molecular complexes and participate in 
diverse signaling assemblies (Feng and Zhang, 2009; Harris and Lim, 2001; Kim and 
Sheng, 2004). These domains were originally discovered as homologous regions in 
diverse signaling proteins (Cho et al., 1992; Woods and Bryant, 1993). The name PDZ is 
an acronym derived from the first three proteins in which these domains were found: 
postsynaptic density-95 (PSD-95), discs-large (DLG) and zona-occludens-1 (ZO-1) 
(Harris and Lim, 2001; Jemth and Gianni, 2007). As depicted in Figure 5, PDZ domains 
are composed of approximately 90 amino acid residues, folded into six beta sheets (βA-
βF) and two alpha helices (αA, αB), forming an extended groove between strand βB and 
helix αB (Harris and Lim, 2001; Jemth and Gianni, 2007). This groove recognizes 
specific PDZ-binding motifs, also referred to as PDZ ligands, found at the extreme 
carboxyl-terminus of transmembrane receptors and ion channels (Harrison, 1996). A 
highly conserved four residue sequence in the carboxylate-binding loop of the extended 
groove, known as the signature Gly-Leu-Gly-Phe (GLGF) motif, forms hydrogen bonds 
with the PDZ ligand (Morais Cabral et al., 1996). The extended groove binds the 
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consensus sequence of the PDZ ligand with varying affinity based on preferential residue 
specificity (Harris and Lim, 2001).  
PDZ domain recognition specificity is dictated by the primary amino acid 
sequence of the C-terminal PDZ-binding motif that binds in the extended groove 
(Songyang et al., 1997). Consensus binding sequences are divided into three main 
categories, defined as Class I (X-(S/T)-X-φ-COOH), Class II (X-φ-X-φ-COOH) and 
Class III (X-X-C-COOH) (Songyang et al., 1997). With the exception of internal β-
hairpin folds, as seen in the binding of neuronal nitric oxide synthase (nNOS) to 
syntrophin (Christopherson et al., 1999), virtually all PDZ domains recognize terminal 
carboxyl motifs (Christopherson et al., 1999; Harris and Lim, 2001; Hillier et al., 1999; 
Trejo, 2005). Even in the case of this internal PDZ motif recognition, the same energetic 
requirements observed in C-terminal binding are maintained because the tertiary structure 
of the internal loop mimics a chain terminus (Gee et al., 1998). The nomenclature of 
these terminal residues is well established; the C-terminal amino acid is termed P0, while 
upstream N-terminal residues are termed P-1, P-2, P-3, etc (Harris and Lim, 2001). Studies 
suggest that residues in the P0 and P-2 position are most important for proper PDZ domain 
recognition and serve as critical docking sites in the binding groove (Jelen et al., 2003; 
Sheng and Sala, 2001).  
Other residues in the PDZ binding motif may confer specificity and serve to fine 
tune the PDZ interaction (Harris and Lim, 2001).   The amino acid residue located at the 
P-3  position also makes contact with the PDZ domain, and has been shown to participate 
in hydrogen bonding of the ligand with the groove (Sheng and Sala, 2001). Ionotropic 
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glutamate receptors (NMDA), voltage-gated sodium channels, and some Shaker 
potassium channels contain a glutamate residue at the P-3 position that may be involved in 
mediating the selectivity of PDZ domain protein interactions (Songyang et al., 1997). In 
the case of Kv1.3, P-3 is occupied by phenylalanine, a nonpolar hydrophobic residue 
containing a benzyl side chain. It is the only member of the Shaker family that does not 
contain either a glutamate or leucine residue at this position (Kim et al., 1995) and 
therefore may be recognized by PDZ domain proteins distinct from other Kv1 channels.  
Moreover, the localization of Kv1.3 may be regulated by specific PDZ interactions that 
are distinct from other Kv1 family channels.    
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Figure 5: The tertiary structure of PDZ domains. PDZ domains are composed of 
approximately 90 amino acids forming six beta strands (βA-βF; blue) and two alpha 
helices (αA, αB; green). Between beta strand B and alpha helix B lies the extended 
groove, which binds the extreme C-terminal PDZ ligand (purple) of transmembrane 
receptors and ion channels.  
 
Kim et al. PDZ domain proteins of synapses.  Nature Reviews Neuroscience. (2004) 5, pp 771-781. 
 
 
 
 
B. Role of PDZ Interactions in Protein Localization 
 
The localization of proteins to distinct cellular compartments strongly influences 
cellular function. Perhaps the most fundamental demonstration of the role PDZ domain 
containing proteins play in compartmental localization is exemplified by the process of 
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polarized signaling. For example, the plasma membrane of epithelial cells is divided into 
apical and basolateral surfaces, which are separated by tight junctions (Kim, 1997; 
Mostov et al., 2003). Maintenance of this cell polarity is crucial for normal cellular 
function and is facilitated by the asymmetrical distribution of receptors, transporters and 
ion channels between these membranes (Kim, 1997; Mostov et al., 2003; Moyer et al., 
1999). PDZ domains are essential components in determining this cellular polarity; they 
have been shown to specifically localize proteins to both the apical and basolateral 
membranes (Fanning and Anderson, 1999).  
 Neurons also have a highly polarized cellular structure, most often composed of 
somatic, dendritic and axonal compartments (Dotti et al., 1988). Several studies have 
shown that PDZ domain interactions are integral for anchoring proteins at specific 
subcellular sites (Harris and Lim, 2001; Kim et al., 1995). These molecular scaffolds help 
maintain the specific protein localization required for neuronal signaling (Kim et al., 
1995; Srivastava et al., 1998). Spatial restriction of Kv1 channels to the axon initial 
segment of neurons is mediated by a macromolecular protein complex involving post-
synaptic density 93 (PSD-93) (Ogawa et al., 2008). In addition, PSD-95 has been shown 
to cluster Kv1 channels in heterologous cells (Kim et al., 1995; Marks and Fadool, 2007), 
as well as differentially recruit these channels into neuronal lipid rafts (Wong and 
Schlichter, 2004), providing further evidence for the role of PDZ domains in protein 
localization.    
 Altering interactions with the C-terminal PDZ binding motif of ion channels leads 
to significant changes in their localization and function (Haggie et al., 2004; Nehring et 
al., 2000; Roche et al., 2001). For example, association of an inward rectifier potassium 
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channel, Kir2.3, with PSD-95 functionally suppresses the activity of the channel by 
reducing its single channel conductance (Nehring et al., 2000). Deleting the PDZ binding 
motif of the NR2B subunit of the ionotropic glutamate receptor, N-methyl-D-aspartate 
(NMDA), results in channel internalization from the plasma membrane (Roche et al., 
2001). Furthermore, removing the PDZ binding motif of the Cystic Fibrosis 
transmembrane conductance regulator (CFTR) disrupts the normal intracellular 
trafficking of the channel, underscoring the importance of this motif in protein 
localization and function (Haggie et al., 2004).  
 Minimal evidence exists for defining the role of the Kv1.3 C-terminal PDZ-
binding motif in regulating the localization and function of this channel. Early studies 
have demonstrated that similar to other Kv1 channels, the C-terminal tail of Kv1.3 
associates with PSD-95 (Kim et al., 1995). Subsequent analyses of Kv1.3-null mice have 
shown that deletion of the channel alters the expression of various scaffolding proteins, 
including PSD-95 (Fadool et al., 2004). These findings are consistent with previous 
observations of the reciprocal regulation of Kv1.3 (Holmes et al., 1997). While Src 
kinase has been shown to suppress Kv1.3 current, the overexpression of Kv1.3 
downregulates Src (Holmes et al., 1997).  A recent study identified the functional 
ramifications of coexpressing Kv1.3 and PSD-95 in a heterologous system (Marks and 
Fadool, 2007). Co-immunoprecipitation of Kv1.3 and PSD-95 is dependent on the 
presence of specific C-terminal residues; phosphorylation-independent point mutations in 
the PDZ-binding motif of Kv1.3 disrupted the channel/adapter complex (Marks and 
Fadool, 2007).  While molecular interaction of the Kv1.3 C-terminal PDZ binding motif 
with PSD-95 is responsible for channel clustering in the plasma membrane, the PSD-95 
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mediated decrease in the activity-dependent peak current magnitude of Kv1.3 relies on 
domain interactions beyond canonical PDZ binding (Marks and Fadool, 2007). The work 
presented in this dissertation is the first to identify a role for the PDZ-binding motif in 
Golgi localization of Kv1.3 and aims to elucidate the functional consequences of 
abolishing this protein interaction motif.  
 
C. PDZ Interactions and the Golgi Apparatus 
 
 
Intracellular localization and trafficking are distinct properties that have been 
shown to extensively influence ion channel function (Gu et al., 2003; Nesti et al., 2004). 
PDZ domains have been shown to contribute to the localization of proteins to 
intracellular organelles, such as the Golgi apparatus (Gentzsch et al., 2003; Guggino, 
2004; He et al., 2004). Several ion channels are known to localize to the Golgi apparatus 
(Cheng et al., 2002; Gentzsch et al., 2003; Zhu et al., 2001). Analysis of the intracellular 
distribution of other Kv1 family channels reveals that Kv1.4 accumulates in the Golgi, 
whereas Kv1.1 and Kv1.2 are primarily found in the ER (Zhu et al., 2001, 2003a). The 
CFTR associates with a Golgi resident protein presumed to tether CFTR to this organelle 
and potentially regulate channel transit to the plasma membrane (Cheng et al., 2002; 
Guggino, 2004). Another chloride channel, ClC-3B, also localizes to the Golgi apparatus 
and has been found to associate with the same Golgi resident proteins as CFTR (Gentzsch 
et al., 2003).  
Biosynthetic trafficking is an important mechanism for determining the level of 
mature protein within a cell and can be regulated at multiple stages (Ma and Jan, 2002; 
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Ma et al., 2001). Although many motifs exist for modulating endoplasmic reticulum (ER) 
retention and export (Zarei et al., 2004; Zhu et al., 2003a), the Golgi apparatus also 
appears to serve as a checkpoint for anterograde protein trafficking (Cheng et al., 2002; 
Gentzsch et al., 2003; He et al., 2002). Glycosylation in the Golgi apparatus is a major 
determinant of protein trafficking to the plasma membrane (He et al., 2002; Watanabe et 
al., 2007; Zhu et al., 2001). For example, a glycosylation-deficient mutant of the beta 1 
adrenergic receptor (β1AR) leads to functional protein production, but decreased receptor 
surface expression (He et al., 2002). Analysis of the intracellular distribution of Kv1 
family channels reveals that Kv1.4 accumulates in the Golgi and illustrates a role for 
trans-Golgi glycosylation in the surface expression of Kv1 channels (Watanabe et al., 
2007; Zhu et al., 2001).  
In addition, protein-protein interactions in the Golgi apparatus also regulate 
biosynthetic trafficking (Cheng et al., 2002; Gentzsch et al., 2003; He et al., 2004). For 
example, CFTR channels interact with the Golgi-associated protein, CFTR-associated 
ligand (CAL) (Cheng et al., 2002). Overexpression of CAL significantly reduces CFTR 
surface expression and ionic current by potentially sequestering the channel to the Golgi, 
an interaction mediated by the C-terminal PDZ-binding motif of the channel (Cheng et 
al., 2002). Since the discovery of CAL, this PDZ domain protein has been found to 
interact with other ion channels in the Golgi apparatus (Gentzsch et al., 2003). The ClC-
3B chloride channel is present primarily in the Golgi, where it also associates with CAL, 
alternatively known as Golgi-associated PDZ and coiled-coil motif containing protein 
(GOPC) (Gentzsch et al., 2003). Finally, the carboxyl terminus of β1AR, which contains 
a PDZ-binding motif, also associates with CAL (He et al., 2004). Overexpression of CAL 
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results in an intracellular accumulation of β1AR, which is accompanied by a concurrent 
decrease in cell surface receptor (He et al., 2004). This dissertation identifies the Kv1.3 
voltage gated potassium channel as being enriched in the Golgi apparatus and explores 
the role of the PDZ-binding motif in this subcellular localization.  
 
V. Summary 
 
 The investigations associated with this project have focused on the function and 
regulation of the Kv1.3 voltage-gated potassium channel. Chapter 2 presents novel 
evidence indicating that Kv1.3 is a determinant of postganglionic sympathetic neuronal 
function. Inhibition of the channel alters resting membrane potential, latency to action 
potential firing, and neurotransmitter release in these cells. Before Chapter 2 was 
published in the American Journal of Physiology, Kv1 mRNAs were known to be 
expressed within sympathetic ganglia (Dixon and McKinnon, 1996), but little was 
understood about the location or function of specific Kv1 channels in these neurons. In 
this chapter, we also show that Kv1.3 exhibits a striking pattern of localization to a 
discrete intracellular compartment, overlapping with a marker for the Golgi apparatus. 
Not only did this research establish the importance of Kv1.3 in sympathetic neuronal 
function, it also unlocked the possibility that Golgi retention of Kv1.3 may play a role in 
regulating the functional properties of these neurons.   
The remainder of this dissertation describes the use of a heterologous expression 
system to focus on the intracellular Golgi localization of Kv1.3 as a potential mechanism 
for channel regulation. This research quantitatively identifies the inverse relationship 
between Kv1.3 Golgi localization and the amount of channel in the plasma membrane. 
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The extreme C-terminal region of Kv1.3 contains a PDZ-binding motif which is known 
to participate in protein-protein interactions that aid channel localization to various 
cellular compartments (Kim et al., 1995). We show that removal of this PDZ-binding 
motif decreases Kv1.3 Golgi localization and increases Kv1.3 ionic current, suggesting 
that Golgi retention may be a mechanism for regulating the amount of functional channel 
in the plasma membrane. Collectively, the work in this dissertation identifies Kv1.3 as an 
important determinant of sympathetic neuronal function and provides insight into the 
regulatory checkpoints of the channel that may serve as targets for Kv1.3-mediated drug 
therapy in human disease. 
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Abstract 
 
Kv1.3 channels are known to modulate many aspects of neuronal function.  We 
tested the hypothesis that Kv1.3 modulates the function of postganglionic sympathetic 
neurons.  RT PCR, immunoblot and immunohistochemical analyses indicated that Kv1.3 
channels were expressed in these neurons.  Immunohistochemical analyses indicated that 
Kv1.3 protein was localized to neuronal cell bodies, processes, and nerve fibers at 
sympathetic neurovascular junctions.  Margatoxin (MgTX), a specific inhibitor of Kv1.3, 
was used to assess the function of the channel.  Electrophysiological analyses indicated 
that MgTX significantly reduced outward currents (p < 0.05; n = 18 (control) and 15 
(MgTX)), depolarized resting membrane potential, and decreased the latency to action 
potential firing (p < 0.05; n = 11 (control) and 13 (MgTX)).  The primary physiological 
input to postganglionic sympathetic neurons is acetylcholine, which activates nicotinic 
and muscarinic acetylcholine receptors.  MgTX modulated nicotinic acetylcholine 
receptor agonist-induced norepinephrine release (p < 0.05; n ≥ 6), and MgTX-sensitive 
current was suppressed upon activation of muscarinic acetylcholine receptors with 
bethanechol (p < 0.05; n = 12).  These data indicate that Kv1.3 affects the function of 
postganglionic sympathetic neurons, which suggests that Kv1.3 influences sympathetic 
control of cardiovascular function.  Our data also indicate that modulation of Kv1.3 is 
likely to affect sympathetic control of cardiovascular function.  
Introduction 
 
The sympathetic nervous system is a major determinant of cardiovascular 
function and is implicated in cardiovascular disease (Carlson et al., 2000; Dakak et al., 
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1995; Dhital et al., 1988; Esler et al., 2006; Fingerle et al., 1991; Guyenet, 2006; Karoon 
et al., 1995; Kolo et al., 2004; Lee et al., 1987; Luo et al., 2003; Sauzeau et al., 2006; 
Schrier and Abraham, 1999).  Many effects of the sympathetic nervous system on 
cardiovascular function are mediated via neurotransmitters released from postganglionic 
sympathetic neurons innervating blood vessels.  The mechanisms governing 
neurotransmitter release at sympathetic neurovascular junctions are not completely 
understood. 
Kv1 family potassium channels consist of eight genes encoding distinct alpha 
subunit proteins, Kv1.1 through Kv1.8, and are expressed throughout the nervous system 
(Dixon and McKinnon, 1996; Guan et al., 2006; Gutman et al., 2003; Hatton et al., 2001; 
Ichikawa and Sugimoto, 2003; Malin and Nerbonne, 2001; Nashmi et al., 2000; 
Popratiloff et al., 2003; Szulczyk et al., 2006; Tsaur et al., 1992; Veh et al., 1995; Wang 
et al., 1994).  Functional Kv1 channels are formed when four Kv1 alpha subunits 
assemble as homotetramers or as heterotetramers with other members of the Kv1 family.  
These channels affect a range of neuronal functions (Dodson et al., 2002; Fadool et al., 
2004; Glazebrook et al., 2002; Haghdoust et al., 2006; Kupper et al., 2002; McFarlane 
and Pollock, 2000; McKay et al., 2005; Mo et al., 2002), including spike frequency 
adaptation (McKay et al., 2005; Mo et al., 2002) and the regulation of cellular excitability 
in response to synaptic input (Glazebrook et al., 2002).  Postganglionic sympathetic 
neurons express Kv1 channels (Dixon and McKinnon, 1996; Malin and Nerbonne, 2001; 
Szulczyk et al., 2006) and inhibition of these channels has been reported to modulate 
neurotransmitter release from these neurons (Ikushima et al., 1981; Jackson et al., 2001; 
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Uhrenholt and Nedergaard, 2003).  However, the mechanisms involved in Kv1 channel 
modulation of neurotransmitter release in sympathetic neurons are largely unexplored. 
Kv1.3 channels play a key role in a wide range of physiological phenomena.  
Kv1.3 is required for the activation of T-lymphocytes, and is thus a determinant of 
immune function (Beeton et al., 2006).  Inhibition of Kv1.3 facilitates translocation of the 
insulin sensitive glucose transporter, GLUT4, to the plasma membrane of adipocytes (Li 
et al., 2006) and skeletal muscle (Xu et al., 2004), and is thus a determinant of glucose 
homeostasis.  Kv1.3 has also been shown to contribute to body weight regulation and 
energy homeostasis, processes that are regulated by the sympathetic nervous system (Xu 
et al., 2003).  In neurons, Kv1.3 has been reported to modulate action potential firing (8, 
26). 
Here we evaluate the role of Kv1.3 in postganglionic sympathetic neuron 
function.  We demonstrate that this channel is present and functional in postganglionic 
sympathetic neurons.  Kv1.3 was detected throughout the neurons, in both soma and 
processes.  It contributed to outward currents recorded from the soma and was a 
determinant of resting membrane potential and neurotransmitter release.  These studies 
show that Kv1.3 channels are important determinants of postganglionic sympathetic 
neuronal function and have important implications for understanding the effects of the 
sympathetic nervous system on cardiovascular function.  
Materials and Methods 
 
Animals. The use of animals in the present studies was in accordance with the National 
Institutes of Health guidelines for the humane care and use of animals in research and 
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was approved by the Institutional Animal Care and Use Committee of the University of 
Vermont.  Neonatal Sprague Dawley rats were used to obtain superior cervical 
sympathetic ganglia (SCG).  Adult postpartum female Sprague Dawley rats were used to 
obtain SCG and tail arteries.  The postpartum females used in the present studies were the 
mothers of the neonatal rats and were used to minimize the number of animals. 
Neuronal Culture.  Postganglionic sympathetic neurons were isolated from the SCG of 
neonatal (3 - 4 days) Sprague Dawley rats (males and females).  Ganglia were dissociated 
for 10 minutes at 37°C in a collagenase/hyaluronidase solution (10 mg/ml bovine serum 
albumin, 4 mg/ml collagenase, 1 mg/ml hyaluronidase in Dulbecco’s phosphate buffered 
saline) and then for 10 minutes in trypsin (3 mg/ml added to trypsin-EDTA).  Dissociated 
cells were resuspended in neuronal growth medium (DMEM/F12 supplemented with 
10% NuSerum (BD Biosciences), 5% fetal bovine serum (Invitrogen) and 
penicillin/streptomycin), supplemented with NGF (BD Biosciences; 50 ng/ml), and 
applied to collagen-coated tissue culture dishes.  The cells were allowed to attach 
overnight in a humidified 5% CO2 environment maintained at 37°C.  Non-neuronal cells 
were then growth arrested with mitomycin C (Sigma; 10 μg/ml for 1 hour).  These 
cultures of neurons will be subsequently referred to as dissociated neurons.  
RT-PCR.  RNA was isolated with RNAeasy mini kits from Qiagen.  Equal amounts of 
RNA were reverse transcribed (RetroScript, Ambion) and equal amounts of cDNA 
amplified (Amplitaq Gold, Applied Biosystems).  PCR primers and annealing 
temperatures are indicated in Table 1.  PCR products were electrophoresed on 1.2% 
agarose gels containing ethidium bromide and visualized with UV light.  All PCR 
reactions included (–) RT and (–) template controls.  Amplified PCR products were 
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sequenced by the University of Vermont DNA facility to confirm the identity of the 
DNA.  
Western Analyses.  Tissues and cells were lysed and homogenized in enhanced RIPA 
buffer (50 mM Tris, 150 mM NaCl, 10 mM EDTA 0.25% deoxycholate 1% NP40, 10% 
glycerol, 1% protease inhibitor cocktail (Sigma), 1 mM dithiothreitol, 0.1% sodium 
dodecyl sulfate; pH 8.0).  Samples were diluted with equal volumes of electrophoresis 
running buffer, boiled for 5 minutes and electrophoresed on 4 – 20% gradient acrylamide 
gels.  Samples were then transferred to nitrocellulose membranes.  The membranes were 
blocked with PBS containing 0.05% Tween and 3% nonfat dry milk (30 minutes at room 
temperature) and then incubated overnight at 4 C in PBS-Tween containing 3% nonfat 
dry milk,  and primary antibody (0.2 μg/ml anti-Kv1.3 (NeuroMab) and 1 μg/ml anti-
Tyrosine Hydroxylase (TH; Sigma)).  The Kv1.3 mouse monoclonal antibody, IgG2a 
isotype, was raised against synthetic peptide amino acids 485-506 of rat Kv1.3 (clone 
L23/27; Lot # 413-5RR-07). The TH mouse monoclonal antibody recognizes the N-
terminal epitope between amino acids 40-152 of rodent and human TH (Lot # 
016K4857).  Unbound primary antibody was removed with three 5 minute washes (PBS-
Tween).  The membranes were then incubated in PBS-Tween containing 3% nonfat dry 
milk and horseradish peroxidase-conjugated secondary antibodies (1:3000; Biorad) for 
one hour at room temperature.  The horseradish peroxidase was detected with enhanced 
chemiluminescence (Pierce) and documented on autoradiographic film.  
Immunofluorescence.  Cultures of postganglionic sympathetic neurons were rinsed in 
PBS and fixed in 4% formaldehyde in PBS for 12 min.  SCG and tail arteries were 
dissected from adult postpartum female rats and fixed in 4% formaldehyde in PBS for 1 
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or 2 hours, respectively.  Ganglia were immersed in 30% sucrose in PBS overnight and 
frozen in Tissue-Tek O.C.T. compound (Electron Microscopy Sciences) and sliced to a 
thickness of 30 µm at -20°C.  SCG sections and dissociated neurons were permeabilized 
with 0.2% Triton X-100 in PBS for 5 min and subsequently rinsed in PBS.  Tail arteries 
were permeabilized with acetone for 5 min and rinsed in PBS.  Cultures, SCG sections, 
and whole mount tail arteries were blocked for 1 hour in 3% goat serum, 0.1% fish skin 
gelatin in PBS.  A rabbit polyclonal TH antibody (0.16 μg/ml; Chemicon), raised against 
denatured rat TH (Lot # 0512016843), was used to identify neurons.  A rabbit polyclonal 
GM130 antibody (0.7 μg/mL; Calbiochem), raised against recombinant protein 
containing amino acids 371-990 of human GM130 (Lot # D00004465), was used to 
identify the Golgi apparatus.  The same monoclonal Kv1.3 antibody (0.84 μg/mL; 
NeuroMab) used for western analyses was also used to identify Kv1.3.  Cells were 
incubated in primary antibodies overnight at 4°C, followed by three 5 min washes in 
PBS.  Alexa Fluor Goat anti-mouse (cultures 568 nm; SCG and tail arteries 647 nm) and 
goat anti-rabbit (488 nm) secondary antibodies (4 μg/ml; Invitrogen) were applied for 1 
hour at room temperature and all samples were mounted using ProLong Gold antifade 
reagent (Invitrogen).  All images were taken using the Olympus IX70 microscope and 
DeltaVision Restoration Imaging System (Applied Precision, LLC) and background 
subtracted with an IgG2a isotype control (R&D Systems). 
Neuronal transfection.  Neurons were transfected using the Helios Gene Gun (BioRad) 
with pEGFP or pEGFP-Kv1.3.  pEGFP coated bullets were a generous gift from Dr. 
Victor May (University of Vermont, Department of Anatomy and Neurobiology).  
pEGFP-C1-Kv1.3 was a generous gift from Dr. Jürgen Kupper ((Kupper, 1998); Max 
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Planck Institute of Biochemistry, Martinsried, Germany).  Cells were studied 48 hrs after 
transfection.              
Electrophysiology.  Electrophysiological recordings were performed at room temperature, 
utilizing the whole cell patch clamp technique.  Data acquisition and analysis were 
obtained using the Axopatch 200B (Axon Instruments) patch clamp amplifier and 
pCLAMP 9.2 (Axon Instruments) software.  Electrodes were pulled in two stages from 
thin wall filament glass capillary tubing (Warner Instruments) and fire polished to a 
resistance ranging from 1 – 2 MΩ.  Voltage clamp recording solutions were as follows 
(in mM):  external (bath) solution 100 NaCl, 5.4 KCl, 1.8 CaCl2. 0.8 MgCl2, 23 glucose, 
5 Na Hepes, 0.001 tetrodotoxin (TTX), 10 tetraethylammonium (TEA), pH 7.4; internal 
(pipette) solution: 120 KCl, 3.69 CaCl2, 0.094 MgCl2, 5 BAPTA, 5 EDTA, 5 Na HEPES, 
5 glucose, pH 7.2.  Pharmacological agents were applied at the following concentrations: 
1 nM Margatoxin (MgTX; Alomone), 100 nM α-Dendrotoxin (DTX; Research 
Biochemicals International) and 100 μM Bethanechol (BeCh; Sigma).  Cells were held at 
-60 mV, followed by a 20 ms hyperpolarization to -90 mV, and stepped from -70 mV to 
+50 mV in 10 mV increments.  Leak currents (P/8) were subtracted from all traces.  
Averaged MgTX traces were subtracted from averaged control traces to obtain the 
resolved Kv1.3 current.  Current clamp recording solutions were the same as listed above, 
except that TTX and TEA were omitted.  Resting membrane potential was monitored for 
100 ms, followed by 400ms current injections of the following magnitudes (in pA): -500, 
500, 1000, 1500, 2000, and 2500.  Latency to action potential firing was defined as the 
time between the start of the current injection and the peak of the action potential.  Action 
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potential width was measured at half the action potential amplitude as previously 
described (Guan et al., 2007).  
Norepinephrine release.  Norepinephrine (NE) release was assessed using tritiated 
norepinephrine purchased from Amersham.  These assays were performed using HEPES-
buffered Krebs solution [122 mM NaCl, 3 mM KCl, 0.4 mM MgSO4 · H2O, 1.2 mM 
KH2PO4, 10 mM Glucose, 20 mM HEPES, 1.3 mM CaCl2 · 2H2O, 1 mM Ascorbic Acid, 
10 μM Pargyline, pH 7.4].  Cells were preincubated at 37ºC with 100 nM tritiated 
norepinephrine for 30 minutes.  The cells were then washed (6 x 5 minutes) and 
stimulated with a nicotinic agonist, dimethylphenylpiperazinium (DMPP; 30 μM; 
Sigma).  The remaining cell associated NE was then extracted with acidified ethanol.  NE 
in all samples was collected and analyzed using a Beckman LS6000IC Liquid 
Scintillation Counter (Beckman Instruments).  Stimulated release was calculated using 
the following equation: (stimulated cpm – background cpm) / (total cpm available for 
release). 
Statistics. Data are presented as means ± standard errors.  Unpaired Student’s t-tests 
assuming unequal variances were used to determine statistical differences.  Differences 
were considered significant if p ≤ 0.05.  
Results 
 
To begin to assess the function of Kv1.3 channels in postganglionic sympathetic 
neurons, we first characterized the expression and subcellular localization of these 
channels.  Kv1.3 mRNA and protein were detected in dissociated neurons (d), and in 
intact neonatal (n) and adult (a) ganglia (figure 1A).  Potassium channel effects on 
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neuronal physiology are strongly influenced by their location within the cell, therefore we 
used immunofluoresence microscopy to examine the subcellular localization of Kv1.3 
protein (figure 1B and 1C).  Neurons were identified with antibodies directed against 
tyrosine hydroxylase.  In dissociated neurons and freshly isolated tissues, Kv1.3 was 
detected in both the soma and processes.  In the soma, Kv1.3 exhibited a striking pattern 
of localization to a discrete intracellular compartment that overlaps with the GM130 
Golgi apparatus marker in dissociated neurons (figure 2).  All dissociated neurons 
observed expressed Kv1.3 and exhibited this intracellular localization pattern.  
Because the striking intracellular localization detected with anti-Kv1.3 is not 
typical for a membrane-associated ion channel, we used GFP-Kv1.3 as an alternate 
approach to assess the subcellular localization of Kv1.3.  The distribution of 
overexpressed GFP-Kv1.3 overlapped with that detected by Kv1.3 immunofluorescence 
(figure 3).  The distribution of overexpressed GFP differed considerably from GFP-Kv1.3 
and Kv1.3 immunofluorescence (figure 3).  Intracellular compartmentalization of Kv1.3 
was also observed in sympathetic neurons in adult ganglia (figure 1C).   
We next determined the function of Kv1.3 in postganglionic sympathetic neurons.  
We used whole cell patch clamp electrophysiology in the absence and presence of 
margatoxin (MgTX), a specific inhibitor of Kv1.3 (Garcia-Calvo et al., 1993).  To resolve 
Kv1.3 currents, all measurements were recorded in the presence of 1 μM TTX and 10 
mM TEA to block currents generated by sodium and non-Kv1 family potassium 
channels.  Steady state currents measured in untransfected dissociated postganglionic 
sympathetic neurons were significantly suppressed by MgTX (1 nM; n = 15) relative to 
control (n = 18; p < 0.02) (figure 4A).  This indicates that endogenous Kv1.3 channels 
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contribute to outward current recorded from the soma of postganglionic sympathetic 
neurons.  To confirm that MgTX inhibited Kv1.3, steady state currents were also 
measured in dissociated postganglionic sympathetic neurons expressing GFP-Kv1.3.  
Outward currents in transfected cells were markedly increased, indicating that GFP-
Kv1.3 was functional in these cells.  MgTX (1 nM) elicited an 86% decrease in this 
current (figure 4B; n = 3; p < 0.002).  Activation curves were generated from tail currents 
and fit to a Boltzmann function.  These curves are shown in figure 4C for both 
endogenous and GFP-Kv1.3.  Half activation voltages (V1/2) determined from these 
curves were -22.8 mV for endogenous MgTX-sensitive current and -27.2 mV for GFP-
Kv1.3, values consistent with previously published reports (Vicente et al., 2008a). 
At concentrations higher than that used in the present studies, MgTX has been 
reported to inhibit Kv1.6 (Garcia-Calvo et al., 1993).  To evaluate the contribution of 
Kv1.6 to the MgTX-sensitive current measured in figure 4A, we measured steady state 
ionic currents in dissociated postganglionic sympathetic neurons in the presence of α-
dendrotoxin (DTX), an inhibitor of Kv1.6, as well as Kv1.1 and Kv1.2 channels (Harvey, 
2001).  DTX (100 nM) had no effect on steady state currents in these cells (p > 0.05; n ≥ 
10) (figure 4D).  Steady state outward currents recorded in HEK 293 cells stably 
transfected with Kv1.2 were significantly suppressed in the presence of DTX (100 nM; n 
= 4; p < 0.05; data not shown), confirming the effectiveness of this inhibitor.  These 
findings support our conclusion that the MgTX-sensitive current shown in figure 4A is 
attributable to Kv1.3. 
Current clamp electrophysiology was used to elucidate the physiological role of 
Kv1.3 current in dissociated postganglionic sympathetic neurons.  Resting membrane 
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potential measured in the presence of MgTX (-45.7 mV ± 2.1; n = 13) was significantly 
depolarized relative to control (-51.9 mV ± 2.3; n = 11; p < 0.05) (figure 5B).  In 
addition, the latency to action potential firing in the presence of MgTX (26.9 ms ± 1.3; n 
= 13) was significantly less than control (39.9 ms ± 5.4; n = 11; p < 0.05) (figure 5C).  
MgTX did not alter the width of the action potential measured at half peak amplitude 
(figure 5D). 
Acetylcholine (Ach) is the preganglionic neurotransmitter for postganglionic 
sympathetic neurons.  ACh activates both nicotinic (nAChR) and muscarinic (mAChR) 
acetylcholine receptors in these neurons (Lechner et al., 2003).  Activation of mAChRs is 
known to suppress ionic current of Kv1 family channels (Huang et al., 1993).  We found 
that bethanechol (BeCh; 100 μM), a mAChR selective agonist, significantly decreased 
outward current measured in dissociated neonatal sympathetic neurons (figure 6A; n = 
12; p < 0.05).  Inhibition of Kv1.3 with MgTX abrogated the effect of BeCh, suggesting 
that activation of mAChRs suppresses Kv1.3 current in these cells (figure 6B; n = 12; p > 
0.05).  In HEK cells lacking muscarinic receptors, but transfected with GFP-Kv1.3, BeCh 
did not decrease Kv1.3 current at any voltage (data not shown; n = 8; p > 0.05).  These 
data indicate that BeCh did not directly affect Kv1.3.     
The ultimate function of postganglionic neurons is to release neurotransmitter, 
thereby affecting the function of sympathetic targets.  Therefore, we assessed the effect of 
Kv1.3 on NE release from these neurons.  Acetylcholine is the physiological stimulus for 
neurotransmitter release from these neurons.  This effect is primarily mediated by 
activation of nAChRs.  Therefore, we used DMPP, a nAChR selective agonist to 
stimulate neurotransmitter release.  Application of 30 μM DMPP stimulated NE release 
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from dissociated neonatal neurons.  Inhibition of Kv1.3 with MgTX (1 nM) increased NE 
release from these cells (figure 7; n = 6; p < 0.05).   
Discussion 
 
The present studies provide novel evidence that Kv1.3 determines the function of 
postganglionic sympathetic neurons.  Expression analyses indicated that Kv1.3 is present 
in these neurons.  Electrophysiological analyses indicated that this channel contributes to 
outward current and the maintenance of resting membrane potential.  Pharmacological 
inhibition of Kv1.3 increased neurotransmitter release.  In addition, we demonstrated that 
this channel was modulated by preganglionic mechanisms.  Postganglionic sympathetic 
neurons are important determinants of cardiovascular function.  Thus, our studies 
strongly suggest that Kv1.3 channels and their modulation are important determinants of 
sympathetic control of cardiovascular function.  
The present studies are the first to demonstrate that Kv1.3 protein is expressed in 
postganglionic sympathetic neurons.  RT-PCR, immunoblot, and immunohistochemical 
analyses indicate that Kv1.3 was in the soma.  Kv1.3 was concentrated in an intracellular 
compartment (figures 1, 2 and 3).  Similar localization of Kv1.3 has been reported in 
other cells and tissues (Guan et al., 2006; O'Connell and Tamkun, 2005).  Figure 2 
indicates that this compartment is the Golgi apparatus.  Kv1.3 was also detected in the 
processes of dissociated neurons as well as in nerve fibers on the adventitial surface of 
freshly isolated tail arteries.  These data suggest that Kv1.3 channels are likely to affect 
the function of postganglionic sympathetic neurons in general and in particular, to affect 
sympathetic control of vascular function.  
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Functional analyses of Kv1.3 indicate that this channel is a determinant of the 
electrophysiological properties of postganglionic sympathetic neurons.  MgTX, a specific 
inhibitor of Kv1.3 (Garcia-Calvo et al., 1993), decreased outward currents measured in 
these cells (figure 4A).  In contrast, DTX, an inhibitor of Kv1.6, Kv1.1 and Kv1.2 
(Harvey, 2001), had no effect on outward currents in these neurons (figure 4D).  This 
indicates that MgTX is specific for Kv1.3, and that Kv1.1, Kv1.2 and Kv1.6 do not 
significantly contribute to the outward current measured in these neurons.  Action 
potential analyses presented in figure 5 indicate that Kv1.3 contributes to the 
maintenance of resting membrane potential.  MgTX significantly decreased the latency to 
action potential firing, consistent with the depolarization of resting membrane potential.  
This is the first demonstration that Kv1.3 affects the function of postganglionic 
sympathetic neurons.  
Our immunohistochemical and functional analyses indicate that Kv1.3 is localized 
to both the plasma membrane and Golgi apparatus in postganglionic sympathetic 
neurons.  We detected Kv1.3 current in non-transfected cells indicating surface 
localization of the channel (figure 4A).  In non-transfected cells, surface expression of 
Kv1.3 was below the level of detection of our immunohistochemical analyses (figure 
1B).  In neurons that were transfected with GFP-Kv1.3, surface expression was easily 
detectable (figure 3).  In both non-transfected and transfected neurons, our 
immunohistochemical analyses detected a fraction of Kv1.3 localized to the Golgi 
apparatus (figures 2, 3).  Cellular localization is an important determinant of ion channel 
function (Lai and Jan, 2006).  Our data thus suggest that Golgi localization or retention 
may be a determinant of surface expression and function of Kv1.3. 
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The primary preganglionic input to these neurons is ACh.  It is well known that 
activation of mAChRs modulates KCNQ potassium channels in postganglionic 
sympathetic neurons and that this modulation affects neurotransmitter release (Lechner et 
al., 2003).  In addition, previous studies indicate that activation of mAChRs modulates 
the function of Kv1 channels (Huang et al., 1993).  We show that activation of mAChRs 
suppresses Kv1.3 current in postganglionic sympathetic neurons (figure 6).  This data 
demonstrates a novel effect of mAChR activation, a novel mechanism of Kv1.3 
modulation, and suggests a new mechanism by which mAChR activation modulates 
membrane excitability.     
In addition to activating mAChRs, release of ACh from preganglionic neurons 
activates nAChRs.  Nicotinic AChR activation is the primary mechanism for generating 
action potentials and eliciting neurotransmitter release from postganglionic sympathetic 
neurons.  We assessed the effects of Kv1.3 on nicotinic receptor-induced NE release.  Our 
data indicate that inhibition of Kv1.3 enhanced NE release (figure 7).  This suggests that 
Kv1.3 is acting to suppress membrane excitability and thereby inhibit neurotransmitter 
release.  These findings are consistent with previous reports demonstrating that inhibition 
of Kv1 family channels enhances neurotransmitter release.  The work of Jackson et al. 
(Jackson et al., 2001) and Uhrenholt et al. (Uhrenholt and Nedergaard, 2003) indicate that 
inhibition of Kv1 channels enhances NE release at sympathetic neurovascular junctions.  
Our findings that Kv1.3 channels are present in processes innervating arteries and that 
MgTX enhances NE release, suggest that these channels play a role in modulating 
sympathetic neurovascular transmission. 
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Our data clearly indicate that Kv1.3 channels influence the function of 
postganglionic sympathetic neurons derived from the SCG of the rat, a representative 
paravertebral sympathetic ganglion.  The postganglionic sympathetic neurons in this 
ganglion innervate many targets including blood vessels (Li and Horn, 2006).  Kv1.3 was 
expressed in all of the neurons that were studied, suggesting that Kv1.3 affects 
sympathetic regulation of all SCG targets.  The studies of Dixon and McKinnon (Dixon 
and McKinnon, 1996) indicate that Kv1.3 is also expressed in prevertebral ganglia 
suggesting a general role for Kv1.3 in postganglionic sympathetic neuronal function.  Our 
finding that Kv1.3 is expressed in the fibers innervating the tail artery (figure 1C) 
strongly suggests that Kv1.3 affects neurotransmitter release at sympathetic 
neurovascular junctions.  This would suggest that Kv1.3 is a determinant of sympathetic 
control of blood flow and blood pressure.  
Perspectives and Significance 
 
Compelling evidence suggests that the sympathetic nervous system contributes to 
the development and/or maintenance of cardiovascular disease (Carlson et al., 2000; 
Dakak et al., 1995; Dhital et al., 1988; Esler et al., 2006; Fingerle et al., 1991; Guyenet, 
2006; Karoon et al., 1995; Kolo et al., 2004; Lee et al., 1987; Luo et al., 2003; Sauzeau et 
al., 2006; Schrier and Abraham, 1999; Small et al., 2002).  Sympathetic activity is 
increased in hypertensive animals and humans, and sympathoinhibition decreases blood 
pressure (Dhital et al., 1988; Guyenet, 2006; Karoon et al., 1995; Kolo et al., 2004; Lee et 
al., 1987; Sauzeau et al., 2006).  Hypertension is also a complication of diabetes and 
obesity.  Elevated sympathetic activity is thought to contribute to these forms of 
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hypertension (Carlson et al., 2000; Esler et al., 2006).  Sympathetic activity is increased 
in many patients with heart failure, and this increased activity contributes to the 
pathology of this disease (Schrier and Abraham, 1999; Small et al., 2002).  The present 
studies suggest that Kv1.3 channels in postganglionic sympathetic neurons are 
determinants of sympathetic activity and therefore are potential therapeutic targets for the 
prevention and treatment of cardiovascular disease. 
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Figure Legends 
 
 
Figure 1:  Kv1.3 channels are present in postganglionic sympathetic neurons.   A) 
RT-PCR (top; n = 2) shows expression of mRNA for Kv1.3 in neonatal dissociated 
neurons (d), neonatal sympathetic superior cervical ganglia (SCG) (n) and adult 
sympathetic SCG (a).  PCR reactions included minus reverse transcriptase (–RT) and 
minus template (-T) controls.  Kv1.3 and tyrosine hydroxylase (TH) immunoblots 
(bottom; n = 2) show corresponding protein expression.  TH was used as a marker of 
postganglionic sympathetic neurons.  Approximate molecular weight is noted with 
arrows.  B) Immunolocalization of Kv1.3 (top) and TH (bottom) in the soma (left) and 
processes (right) of dissociated postgangalionic sympathetic neurons in vitro (n = 2).  
Scale bar = 10μm.  C) Immunolocalization of Kv1.3 (top) and TH (bottom) in neuronal 
soma of intact adult sympathetic SCG (left) and of processes innervating adult rat tail 
arteries (right) (n = 2).  SCG scale bar = 10μm; tail artery scale bar = 30μm.  
 
Figure 2:  Kv1.3 overlaps with a marker for the Golgi Apparatus in postganglionic 
sympathetic neurons.  Immunoreactivity of endogenous Kv1.3 (red) overlaps with the 
Golgi marker, GM130 (green), in the soma of dissociated postganglionic sympathetic 
neurons.  The far right panel depicts the overlap between these two antibodies (merge; n 
= 3).  Scale bar = 10μm. 
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Figure 3:  Localization of transfected GFP-Kv1.3 versus endogenous Kv1.3 in 
postganglionic sympathetic neurons.  GFP-Kv1.3 (top left) and immunoreactive Kv1.3 
(top right) overlap in postganglionic sympathetic neurons (n = 3).  Neurons transfected 
with GFP only (bottom left) do not overlap with immunoreactive Kv1.3 (bottom right) (n 
= 3).  Scale bar = 10μm. 
 
Figure 4: Voltage clamp analyses of Kv1.3 in postganglionic sympathetic neurons.  
A) Ionic current measured in untransfected dissociated sympathetic neurons in the 
absence (control; n = 18) and presence of 1 nM Margatoxin (MgTX; n = 15).  Current 
traces for each condition represent the average of unpaired measurements made in 
multiple cells.  * indicates MgTX was significantly different from control (p ≤ 0.05; 
unpaired t-test).  Resolved Kv1.3 current was obtained by subtracting MgTX from 
control.  B) Ionic current measured in dissociated sympathetic neurons transfected with 
GFP-Kv1.3 in the absence (control; n = 3) and presence of 1 nM MgTX (n = 3).  Current 
traces for each condition represent the average of unpaired measurements made in 
multiple cells.  * indicates MgTX was significantly different from control (p ≤ 0.02; 
unpaired t-test).  Resolved GFP-Kv1.3 current was obtained by subtracting MgTX from 
control.  C) Activation curves were plotted from the tail current of endogenous Kv1.3 and 
GFP-Kv1.3 and fit to a Boltzmann equation.  D) Ionic current measured in dissociated 
sympathetic neurons in the absence (control; n = 10) and presence of 100 nM DTX (n = 
18; p > 0.05).  
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Figure 5: Current clamp analyses of Kv1.3 in postganglionic sympathetic neurons.  
A) Representative traces of phasic action potentials recorded from the soma of 
dissociated postganglionic sympathetic neurons in the absence (control; black line) and 
presence (MgTX; red line) of 1 nM MgTX.  B) The resting membrane potential, C) the 
latency to action potential firing, and D) the action potential width as measured at half the 
action potential amplitude in the absence (open bars; n = 11) and presence (closed bars; n 
= 13) of 1 nM MgTX.  * indicates MgTX was significantly different from control (p < 
0.05; unpaired t-test). 
 
 
Figure 6: Preganglionic modulation of Kv1.3 in postganglionic sympathetic neurons.  
A) Steady state current-voltage curves for postganglionic sympathetic neurons in the 
absence (open symbols) and presence (closed symbols) of muscarinic acetylcholine 
receptor activation using 100μM Bethanechol (BeCh).  B) Steady state current-voltage 
curves for postganglionic sympathetic neurons treated with 1nM MgTX in the absence 
(open symbols) and presence (closed symbols) of 100μM BeCh.  * indicates BeCh was 
significantly different from control (n = 12; p < 0.05; unpaired t-test). 
 
Figure 7: Kv1.3 affects norepinephrine release from postganglionic sympathetic 
neurons.  Tritiated norepinephrine release from neuronal cultures in response to a 30 μM 
dimethylphenylpiperazinium (DMPP) treatment in the absence (open bar) and presence 
(closed bar) of MgTX (1 nM, 10 min).  * indicates MgTX was significantly different 
from control (p < 0.05; unpaired t-test). 
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Tables 
 
 
Table 1: Forward and reverse PCR primer sequences 
 
 
mRNA Primer Sequences Annealing Temp 
(°C) 
Kv1.3 5’-GTA CTT CGA CCC GCT CCG CAA TGA -3’ 
5’-GGG CAA GCA AAG AAT CGC ACC AG -3’ 
59 
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Figure 1: Kv1.3 channels are present in postganglionic sympathetic neurons. 
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Figure 2: Kv1.3 overlaps with a marker for the Golgi Apparatus in postganglionic 
sympathetic neurons. 
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Figure 3: Localization of transfected GFP-Kv1.3 versus endogenous Kv1.3 in 
postganglionic sympathetic neurons. 
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Figure 4A: Voltage clamp analyses of Kv1.3 in postganglionic sympathetic neurons. 
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Figure 4B: Voltage clamp analysis of Kv1.3 in postganglionic sympathetic neurons. 
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Figure 4C: Voltage clamp analysis of Kv1.3 in postganglionic sympathetic neurons. 
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Figure 4D: Voltage clamp analysis of Kv1.3 in postganglionic sympathetic neurons. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
88
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Current clamp analyses of Kv1.3 in postganglionic sympathetic neurons. 
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Figure 6: Preganglionic modulation of Kv1.3 in postganglionic sympathetic neurons. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
90
 
 
 
 
 
 
 
 
 
 
Figure 7: Kv1.3 affects norepinephrine release from postganglionic sympathetic 
neurons. 
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Abstract 
 
The voltage-gated potassium channel, Kv1.3, plays an important role in regulating 
membrane excitability in diverse cell types ranging from neurons to T-lymphocytes. 
Subcellular localization of ion channels is a key mechanism for determining their 
function. We observed that Kv1.3 is localized primarily to the Golgi apparatus and the 
plasma membrane. The degree of Kv1.3 Golgi localization is inversely correlated with 
the amount of channel at the plasma membrane. The amplitude of Kv1.3 ionic current 
measured in cells with low Kv1.3 Golgi localization was significantly greater than the 
current measured in cells with high Kv1.3 Golgi localization. We therefore hypothesized 
that Golgi localization is a determinant of Kv1.3 function. One mechanism for localizing 
ion channels to the Golgi apparatus involves the Class I PDZ-binding motif (X-S/T-X-Φ). 
The C-terminal region of Kv1.3 contains a canonical PDZ-binding motif. Deletion of this 
motif decreases Kv1.3 Golgi localization and increases channel localization at the cell 
surface. Deletion of this region also increased the amplitude of Kv1.3 ionic current. We 
propose that Golgi retention serves as a checkpoint for regulating the surface expression 
and function of Kv1.3. 
 
Introduction 
 
The Kv1.3 voltage-gated potassium channel is a key determinant of function in 
many cell types. Kv1.3 plays a central role in regulating resting membrane potential, 
Ca2+ signaling cascades, and antigen-dependent activation and proliferation in T-
lymphocytes, key mediators of autoimmune disease (Beeton et al., 2006; Panyi, 2005; 
Panyi et al., 2004b). In adipocytes and skeletal muscle, Kv1.3 influences glucose 
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transport, (Desir, 2005; Li et al., 2006; Li et al., 2007) and studies in Kv1.3 deficient 
mice indicate that the channel is a determinant of body weight and energy homeostasis 
(Fadool et al., 2004; Tucker et al., 2008; Xu et al., 2003). Several studies also 
demonstrate that Kv1.3 influences neuronal resting membrane potential, action potential 
characteristics, neurotransmission, and synaptic refinement (Biju et al., 2008; Doczi et 
al., 2008; Kupper et al., 2002), further underscoring the physiological significance of 
Kv1.3 in multiple cellular processes.  
The localization of ion channels to distinct cellular compartments can influence 
cellular function. For example, activity-regulated local translation of Kv1.1 in 
hippocampal dendrites contributes to channel surface expression, potentially modulating 
local cellular excitability (Raab-Graham et al., 2006). Modulated endocytosis of Kv1.2 
facilitates both positive and negative plasma membrane trafficking of the channel in 
HEK293 cells, in turn altering Kv1.2 activity at the cell surface (Connors et al., 2008; 
Nesti et al., 2004). Plasma membrane expression of the Cystic Fibrosis transmembrane 
conductance regulator (CFTR), a chloride channel that is enriched in the Golgi apparatus, 
is potentially regulated via channel transit from the Golgi to the plasma membrane 
(Cheng et al., 2002; Cheng et al., 2004; Guggino, 2004; Moyer et al., 2000). Previous 
work from our laboratory indicates that in postganglionic sympathetic neurons, Kv1.3 
also exhibits localization to the Golgi apparatus (Doczi et al., 2008). In this study, we 
propose that Kv1.3 Golgi localization is a mechanism for regulating channel activity at 
the cell surface, in turn influencing cellular function.  
One mechanism for localizing ion channels to the Golgi apparatus involves the 
Class I PDZ-binding motif (X-S/T-X-Φ). This motif is found at the extreme carboxy-
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terminus of proteins and serves as a ligand for the binding of postsynaptic density-
95/discs-large/zona-occludens-1 (PDZ) domain containing proteins (Hung and Sheng, 
2002). CFTR channels contain a PDZ-binding motif that associates with the Golgi 
localized PDZ domain protein, CFTR associated ligand (CAL), potentially tethering the 
channel to this subcellular compartment (Cheng et al., 2002; Cheng et al., 2004; Guggino, 
2004; Moyer et al., 2000). The ClC-3B chloride channel is a PDZ-binding isoform of the 
ClC family that also exhibits intracellular localization to the Golgi apparatus (Gentzsch et 
al., 2003). Similarly, ClC-3B transit from the Golgi to the plasma membrane is dependent 
upon interactions with PDZ domain proteins. Potassium channels also contain PDZ-
binding motifs and interactions of these motifs with PDZ proteins play a role in channel 
localization. For example, the PDZ domain containing scaffold protein, Postsynaptic 
density-93 (PSD-93), induces clustering of Kv1 channels to the axon initial segment in 
neurons (Ogawa et al., 2008). Altering associations with the C-terminal PDZ-binding 
motif of potassium ion channels can lead to significant changes in channel function 
(Cheng et al., 2002; Cheng et al., 2004; Guggino, 2004; Mery et al., 2002; Swiatecka-
Urban et al., 2002). Coexpression of an inward rectifier potassium channel, Kir2.3, with 
the synaptic adaptor protein, post synaptic density 95 (PSD-95), functionally suppresses 
the activity of the channel by reducing its single channel conductance (Nehring et al., 
2000).  
The C-terminus of Kv1.3 contains a PDZ-binding motif which is known to 
associate with PDZ domain containing proteins (Kim et al., 1995). A recent study 
demonstrates that PSD-95 clusters Kv1.3 channels into specific membrane microdomains 
(Marks and Fadool, 2007). In addition, PSD-95 also suppresses the current magnitude of 
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Kv1.3 channels via an activity-dependent mechanism (Marks and Fadool, 2007). Thus, 
PDZ interactions play an integral role in the localization and function of Kv1.3.  
In the present study, we test the hypothesis that the PDZ-binding motif of Kv1.3 
plays a role in regulating the intracellular Golgi localization and electrophysiological 
function of the channel. We show that Golgi localization of WT Kv1.3 is inversely 
correlated with surface expression of the channel. Disrupting the C-terminal PDZ-binding 
motif of Kv1.3 significantly decreased Golgi localization of the channel. In addition, this 
mutation also caused an increase in Kv1.3 ionic current. These findings suggest that the 
PDZ-binding motif dependent localization of Kv1.3 to the Golgi apparatus is a 
mechanism for regulating the level of functional channel at the cell surface.  
 
Materials and Methods 
 
Cell Culture and Transient Transfection- Clonal human embryonic kidney 293 
(HEK293) cells were maintained in DMEM/F-12 (Invitrogen) supplemented with 10% 
fetal bovine serum, 10 U/ml penicillin and streptomycin, and 2 mM L-glutamine. Cells 
were transiently transfected with 3.0ug of GFP-Kv1.3/-Flag or GFP-Kv1.3-∆TDV/-Flag 
using the Lipofectamine LTX transfection reagent (Invitrogen). Confluent transfected 
cultures were plated to a low density (25,000 cells/cm2) onto poly-D-lysine-coated tissue 
culture plates (Corning Glass Works) and subsequently placed in serum-free medium 
overnight for experimentation the following day. 
Mutagenesis– All mutagenesis reactions were performed using the Quickchange 
Lightning Site-Directed Mutagenesis Kit (Strategene), following the manufacturer’s 
protocol. The GFP-Kv1.3-∆TDV truncation was created by inserting two premature stop 
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codons into the wild-type channel using the following primer sequence and its reverse 
complement: 5’-GTCAACATCATCAAAAAGATATTCTGATGAACTGA 
TGTCTAATAGGGATCCACC-3’. Similar to previous reports (Panyi et al., 2003; Panyi 
et al., 2004a), the Flag epitope was created by inserting the amino acid sequence, 
DYKDDDDK, into the first extracellular loop of GFP-Kv1.3/-∆TDV and incorporating 
D222 as the first aspartic acid residue in the Flag epitope using the following primer 
sequence and its reverse complement: 5’- 
TCTCCGTCGCAGGACTACAAGGACGACGACGACAA GGTGTTTGAGGCTGCC-
3’.  
Immunofluorescence– To detect Kv1.3 on the cell surface, transiently transfected 
HEK293 cells were live labeled with anti-Flag M2 antibody (1ug/mL; Sigma) at 37°C for 
15 min. Cells were then rinsed 3 x 5 min in PBS, fixed in 4% formaldehyde in PBS for 
20 min, and subsequently permeabilized with acetone for 5 min and rinsed in PBS. Cells 
were then blocked for 20 min at 37°C in 3% goat serum, 0.1% fish skin gelatin in PBS. 
Cells were incubated 20 min at 37°C in a rabbit polyclonal GM130 antibody (0.7 μg/mL; 
Calbiochem), raised against recombinant protein containing amino acids 371-990 of 
human GM130 (Lot # D00004465), to identify the Golgi apparatus and subsequently 
rinsed 3 x 5 min in PBS. Alexa Fluor goat anti-mouse (647 nm) and goat anti-rabbit (568 
nm) secondary antibodies (4.0 g/ml; Invitrogen) were applied for 20 min at 37°C and 
all samples were mounted using ProLong Gold antifade reagent (Invitrogen). All images 
were taken using the Olympus IX70 microscope and DeltaVision Restoration Imaging 
System (Applied Precision, LLC). Golgi Localization was quantified as follows: Golgi 
region of interest (ROI) was defined using the GM130 marker, and the amount of GFP-
 
 
 
 
97
Kv1.3 signal intensity present in the Golgi ROI was expressed as a percent of the total 
GFP-Kv1.3 signal for the entire cell ((GFP-Kv1.3 in Golgi region / Total GFP-Kv1.3) X 
100). Surface expression was quantified as follows: the intensity of the live labeled anti-
Flag M2 antibody was normalized to the total GFP-Kv1.3-Flag intensity of the cell 
(surface Kv1.3/ total Kv1.3).  
Immunoblot Analysis - Cells were washed with ice-cold phosphate-buffered saline and 
lysed in radioimmune precipitation assay buffer (50 mM Tris, 150 mM NaCl, 11 mM 
EDTA, 0.25% deoxycholate, 1% Nonidet P-40, 10% glycerol, 1 mM NaF, 1 mM 
Na3VO4, 1 mM Na4 BAPTA, 1mM dithiothreitol, protease inhibitors (Sigma, catalog no. 
P8340), phosphatase inhibitors (Calbiochem, catalog nos. 524624 and 524625), pH 8.0). 
The lysate was centrifuged at 20,000 x g for 5 min, and the resulting supernatant was 
combined with sample buffer and separated by SDS-PAGE. Western blotting detection of 
Kv1.3 was done with anti-Kv1.3 monoclonal antibody (0.42ug/mL; NeuroMab). A 
monoclonal anti-GAPDH antibody (1.0ug/mL; Millipore) was used to control for loading 
efficiency. Blots were imaged and quantified with the Odyssey infrared imaging system 
(Li-Cor Biosciences). 
Electrophysiology-Electrophysiological recordings were performed at room temperature, 
utilizing the whole cell patch clamp technique.  Data acquisition and analysis were 
obtained using the Axopatch 200B (Axon Instruments) patch clamp amplifier and 
pCLAMP 9.2 (Axon Instruments) software.  Electrodes were pulled in two stages from 
thin wall filament glass capillary tubing (Warner Instruments) and fire polished to a 
resistance ranging from 1 – 2 MΩ.  Voltage clamp recording solutions were as follows 
(in mM):  external (bath) solution 100 NaCl, 5.4 KCl, 1.8 CaCl2. 0.8 MgCl2, 23 glucose, 
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5 Na Hepes, pH 7.4; internal (pipette) solution: 120 KCl, 3.69 CaCl2, 0.094 MgCl2, 5 
BAPTA, 5 EDTA, 5 Na HEPES, 5 glucose, pH 7.2. Cells were held at -60 mV, followed 
by a 20 ms hyperpolarization to -90 mV, and stepped from -70 mV to +50 mV in 10 mV 
increments.  Leak currents (P/8) were subtracted from all traces.  
 
MBP Pulldown– pMAL-Kv1.3-C-term, pMAL-Kv1.3∆TDV-C-term, and the empty 
pMAL vector were transformed into BL21 Gold bacterial cells (Strategene). Cultures 
were grown in LB supplemented with Glucose/Ampicillin and protein expression was 
induced by adding 0.3mM IPTG for 2 hours. Cells were harvested at 4000x g for 10 min 
and resuspended in Column Buffer (20mM Tris-HCl, 200mM NaCl, 1mM EDTA, 1mM 
sodium azide, 1mM DTT). Cells were lysed and the protein extracts (MBP-Kv1.3, MBP-
∆TDV or MBP) were coated onto Amylose resin (New England Biolabs). HEK293 cells 
transfected with pGW1-CMV-myc-PSD-95 were lysed in RIPA and precleared with 
MBP coated Amylose resin by rocking for 30 min at 4°C. Precleared myc-PSD-95 
lysates were then rocked with either MBP-Kv1.3, MBP-∆TDV or MBP coated Amylose 
resin for 30 min at 4 °C, washed 3x in RIPA, needle aspirated, combined with sample 
buffer and separated by SDS-PAGE. Western blotting detection of myc-PSD-95 was 
done with an anti-Myc monoclonal antibody (0.1 ug/mL; Invitrogen) and Kv1.3 was 
detected using an anti-Kv1.3 monoclonal antibody (0.42 ug/mL; NeuroMab). Blots were 
imaged and quantified with the Odyssey infrared imaging system (Li-Cor Biosciences). 
Statistical Analysis - Data are presented as means ± standard errors. As noted, either 
nonparametric Man-Whitney U tests, unpaired Student’s t-tests assuming unequal 
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variances, or one-way ANOVA with post hoc Bonferroni test were used to determine 
statistical differences.  Differences were considered significant if p ≤ 0.01. 
Results  
 
Golgi localization of Kv1.3- Previous studies have shown that Kv1.3 is localized to the 
Golgi apparatus in postganglionic sympathetic neurons (Doczi et al., 2008). The present 
study explores the role of Kv1.3 Golgi localization on channel function using HEK293 
cells as a model system. To determine the degree of Kv1.3 concentration in the Golgi 
apparatus, cells were transfected with GFP-Kv1.3, processed for immunofluorescence 
and labeled with the Golgi apparatus marker, anti-GM130, to delineate the Golgi region. 
For each cell, GFP-Kv1.3 intensity was measured in two regions of interest: one 
encompassing the entire cell (total Kv1.3) and one in the Golgi region (Golgi Kv1.3). 
Golgi localization (%) was calculated as ((Golgi Kv1.3 / total Kv1.3) X 100). Figure 1A 
illustrates that Kv1.3 has a distribution in the Golgi compartment ranging from 8.4 % to 
50 %, with a mean Golgi localization of 28.5 % ± 3.1 (n = 20). The photomicrographs in 
Fig 1B were selected to depict GFP-Kv1.3 transfected cells exhibiting Golgi localization 
in both the upper range above the mean (46.0%; top) and the lower range below the mean 
(9.6%; bottom).  
The Golgi distribution of Kv1.3 is distinct from that observed with a closely 
related channel, Kv1.2 (Fig. 1A). The mean Golgi localization of GFP-Kv1.2 (12.6 % ± 
0.85; n = 20) was significantly less than mean Golgi localization of GFP-Kv1.3 (28.5% ± 
3.1; n = 20; p < 0.0001). A representative photomicrograph depicting the intracellular 
distribution of Kv1.2 is shown in Figure 1C. These data suggest that the high Golgi 
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enrichment of GFP-Kv1.3 is a property of the channel itself, and is not a general property 
of Kv1 channels expressed in HEK293 cells.  
 
Kv1.3 surface expression is inversely related to Golgi localization of the channel- 
In addition to enrichment in the Golgi apparatus, Kv1.3 is also present in the plasma 
membrane (Doczi et al., 2008). Because anterograde trafficking of proteins to the plasma 
membrane can be regulated at the level of the Golgi apparatus, we hypothesized that 
Kv1.3 Golgi localization may be a determinant of Kv1.3 surface expression. To measure 
the amount of GFP-Kv1.3 localized to the plasma membrane, we introduced a FLAG 
epitope (DYKDDDDK) into the extracellular loop between S1 and S2 transmembrane 
helices (GFP-Kv1.3-Flag). Electrophysiological studies shown in Figure 2 confirm no 
significant difference between B) the outward current or C) the half activation voltage of 
GFP-Kv1.3 (open symbols) and GFP-Kv1.3-Flag (closed symbols). 
  To determine if Golgi localization of Kv1.3 influences its surface expression, we 
quantified each parameter within the same cell. Fluorescence microscopy was used to 
measure total Kv1.3 protein and immunofluorescence analysis was used to measure Golgi 
localized Kv1.3 and surface Kv1.3. Surface Kv1.3 was labeled by applying anti-Flag M2 
antibody to live cells. The representative photomicrographs shown in Figure 2B illustrate 
a cell transfected with GFP-Kv1.3-Flag (green) and live labeled with anti-Flag-M2 (blue) 
to detect the extracellular Kv1.3-Flag epitope. The restriction of Flag signal to the plasma 
membrane, and the absence of Flag signal in the Golgi apparatus, confirmed the anti-Flag 
M2 antibody had access only to channel at the cell surface. To quantify Kv1.3 surface 
expression, the intensity of the live labeled anti-Flag M2 antibody was normalized to the 
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total GFP-Kv1.3-Flag intensity of the cell (surface Kv1.3/ total Kv1.3). Linear regression 
analysis revealed that Kv1.3 surface expression was inversely correlated with Golgi 
localization of the channel (R-squared = 0.56; n = 82) (Fig 2D). These data indicate that 
cells with increased Kv1.3 Golgi localization exhibit decreased expression of the channel 
at the cell surface, suggesting the Golgi apparatus may serve as an internal reservoir for 
the channel. 
To facilitate analysis, cells were binned into two categories based on their 
distribution relative to the median percent Golgi localization. Cells are described as 
having high or low Kv1.3 Golgi localization if the percent channel Golgi localization 
falls above or below the median, respectively. Figure 2E depicts the surface expression of 
GFP-Kv1.3-Flag channels exhibiting high or low Golgi localization. The median Golgi 
localization for GFP-Kv1.3-Flag transfected cells was 15.9%. Figure 2E demonstrates the 
normalized surface expression (Kv1.3 surface/Kv1.3 total) of GFP-Kv1.3-Flag in the low 
Golgi localized population (n = 41; mean = 2.2 ± 0.12) was significantly higher than the 
surface expression of the high Golgi localized Kv1.3 population (n = 41; mean = 1.0 ± 
0.10; p < 0.01) (Fig 2E).  
 
Golgi localization and Kv1.3 ionic current- We next asked if the increase in 
surface expression of Kv1.3 is a determinant of channel function. Since Kv1.3 Golgi 
localization was inversely correlated with surface expression, we tested the hypothesis 
that a similar relationship exists between Kv1.3 Golgi localization and Kv1.3 ionic 
current. Because electrophysiological recordings were performed in live cells, we 
visually categorized GFP-Kv1.3 transfected cells as having either high or low Golgi 
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localization before each recording. To confirm that visual categorization parallels the 
previous immunofluorescence data (Fig 2E), we conducted a blind assay to assign 
previously captured photomicrographs of GFP-Kv1.3-Flag transfected cells into high and 
low Golgi localized bins. The results of that visual categorization were then compared to 
the quantitative categorization. Visual categorization correctly binned 79.3% of cells into 
their respective high Golgi localized (above the median) and low Golgi localized (below 
the median) category. No high Golgi cells were incorrectly identified as low Golgi.   
Therefore any inaccurate visual categorization would only underestimate the significance 
of the data presented.    
Steady-state ionic current was measured from cells visually categorized as having 
high (Fig 3A) or low (Fig 3B) channel localization to the Golgi apparatus. The traces 
depicted in Figure 3 represent the average outward current recorded from cells in each 
category. Steady-state current voltage relationships were plotted for cells exhibiting both 
high (closed symbols) and low (open symbols) Kv1.3 Golgi localization (Fig 3C). The 
outward current from cells categorized as having high Kv1.3 Golgi localization (18.2 nA 
± 2.1; n = 15) was significantly lower than cells categorized as having low Kv1.3 Golgi 
localization (26.0 nA ± 2.4; n = 12; p < 0.05). There was no significant difference in the 
voltage dependence of high and low Golgi localized Kv1.3 channels (Fig 3D), indicating 
that the increase in outward current was not due to a decreased voltage dependence of 
channel activation. These data suggest that Kv1.3 ionic current may depend on Golgi 
localization of the channel.  
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Disrupting the C-terminal PDZ binding motif of Kv1.3 decreases Golgi localization of 
the channel- The C-terminal region of Kv1.3 contains a PDZ- binding motif which is 
known to associate with PDZ domain containing proteins, aiding in localization and 
function of the channel to various cellular compartments (Marks and Fadool, 2007). To 
determine the importance of this motif in Kv1.3 Golgi localization, we created a 
truncated form of the channel lacking the last three amino acids (∆TDV). Equal amounts 
of GFP-Kv1.3-WT (WT) and GFP-Kv1.3-∆TDV (∆TDV) were separately transfected 
into HEK293 cells and immunoblot analyses indicate no significant difference in total 
channel protein (Fig 4A). Both WT and ∆TDV bands were detected at the expected 
molecular mass of 100-kDa. Equal loading was confirmed by normalizing both WT and 
∆TDV band densities to glyceraldehyde-3 phosphate dehydrogenase (GAPDH). There 
was no significant difference in the corresponding mean densitometry between WT (n = 
8; 1.0 ± 0.7) and ∆TDV (n = 8; 0.92 ± 0.14; p = 0.29).  
To confirm that the ∆TDV truncation successfully disrupted the PDZ binding 
motif of Kv1.3 and abolished the binding of PDZ domain containing proteins, we 
performed a standard pulldown assay using PSD-95, a canonical PDZ domain containing 
protein known to bind to Kv1.3 (Kim et al., 1995; Marks and Fadool, 2007). The pMAL-
Kv1.3-C-term construct was used to express Maltose Binding Protein (MBP) fused to the 
C-terminal region of Kv1.3. In addition to MBP-Kv1.3-C-term (WT), two other fusion 
proteins were created: MBP-Kv1.3- ∆TDV (∆TDV) and a MBP-only (MBP) control. 
MBP, WT, and ∆TDV coated beads were incubated with HEK293 cell lysates containing 
myc-PSD95. Figure 4B illustrates that PSD95 binds to the C-terminus of Kv1.3-WT and 
that binding is abolished with the ∆TDV truncation.  
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 To address the hypothesis that the PDZ binding motif of Kv1.3 contributes to 
Golgi localization of the channel, HEK293 cells were transfected with GFP-Kv1.3-∆TDV 
(∆TDV) and processed for immunofluorescence. To quantify Golgi localization of 
∆TDV, we used the Golgi apparatus marker, anti-GM130. Figure 4D illustrates that 
Golgi localization of ∆TDV (11.12% ± 1.4; n = 20) was significantly less than WT 
(28.5% ± 3.0; n = 20; p < 0.0001). In fact, all ∆TDV data points fell below the WT mean 
(Fig 4D). The representative photomicrograph in Fig 4C depicts the intracellular 
localization of Kv1.3-∆TDV (9.8%). These data show that removal of the PDZ binding 
motif of Kv1.3 decreases Golgi localization of the channel and suggest that this motif 
may be involved in the Golgi-mediated regulation of the channel.    
 
Disrupting the C-terminal PDZ binding motif of Kv1.3 increases outward functional 
current and plasma membrane expression of the channel-  We next tested the hypothesis 
that the PDZ binding motif of Kv1.3 contributes not only to Golgi localization, but also 
surface expression and Kv1.3 channel function. Steady-state outward current was 
measured from GFP-Kv1.3-Flag-WT transfected cells exhibiting both high (15.5 mV ± 
0.78; n = 15) and low (9.2 mV ± 0.77; n = 15) channel Golgi localization (Figure 5A and 
B). Recordings from both high and low Golgi localized GFP-Kv1.3-Flag-WT 
demonstrate increased outward current in the low Golgi localized cells. This finding 
parallels the previous electrophysiological data for GFP-Kv1.3 (Fig 3) and indicates that 
introducing the Flag epitope does not alter the significant difference in current between 
the high and low Kv1.3 Golgi localized cells. Since we found that the ∆TDV truncation 
decreased Golgi localization of Kv1.3, we hypothesized that deleting this PDZ binding 
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motif would more closely represent the current conducted from the low Golgi localized 
Kv1.3 channels and in turn increase outward functional current. Steady-state outward 
current measured from GFP-Kv1.3-Flag-∆TDV (16.1 mV ± 1.0; n = 27) transfected 
HEK293 cells indicate that the channel is functional and that disrupting the PDZ binding 
motif significantly increases Kv1.3 outward current (Fig 5C). The corresponding current–
voltage relationships (Fig 5D) for high and low Golgi localized GFP-Kv1.3-Flag-WT and 
GFP-Kv1.3-Flag-∆TDV (∆TDV) demonstrate that outward current recorded from the 
∆TDV channels is significantly higher than high Golgi localized WT Kv1.3. There is no 
significant difference between outward current of ∆TDV and the low Golgi localized WT 
Kv1.3 channel. Activation curves for high and low Golgi localized WT and ∆TDV were 
plotted from tail currents and fit to a Boltzmann equation to determine the half activation 
voltages (V1/2) for each channel (Fig. 5E).  No significant difference was observed in the 
V1/2 for WT (-20.7 mV ± 1.4; n = 15) and ∆TDV (-21.2 ± 0.94; n = 27; p > 0.05) 
channels, indicating that the increase in ∆TDV current is not due to alterations in voltage 
dependence.  
 To test the hypothesis that the observed increase in Kv1.3 current is due to 
increased channels at the cell surface, we performed an immunofluorescence assay to 
measure both Golgi localization and surface expression of GFP-Kv1.3-Flag-∆TDV 
transfected HEK293 cells. Similar to the non Flag construct, the Golgi localization of 
GFP-Kv1.3-Flag-∆TDV (11.6% ± 0.57; n = 59) was significantly less than GFP-Kv1.3-
Flag-WT (21.7% ± 1.6; n = 82; p < 0.0001). For the purpose of comparison, the GFP-
Kv1.3-Flag-WT surface expression data from Figure 2E is shown. As described earlier, 
the WT population was binned into two categories, high and low, based on median Golgi 
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localization (16.0%). A one-way ANOVA followed by post hoc Bonferroni test for 
multiple comparisons revealed the normalized surface expression of GFP-Kv1.3-Flag-
∆TDV (n = 59; mean = 1.6 ± 0.11) was significantly higher than surface expression of 
high Golgi GFP-Kv1.3-Flag-WT (n = 41; mean = 1.0 ± 0.10; p < 0.0001) and lower than 
low Golgi GFP-Kv1.3-Flag-WT (n = 41; mean = 2.2 ± 0.12; p > 0.05), suggesting that 
the ∆TDV truncation decreases Golgi localization of Kv1.3, while increasing surface 
expression of the channel. Coupled with the increase in ionic current, these data also 
suggest the PDZ binding-motif disruption-mediated increase in Kv1.3 plasma membrane 
expression may involve a novel mechanism for anterograde Golgi trafficking of the 
channel. 
 
 
 
Discussion 
 
Subcellular localization and trafficking are distinct properties that have been 
shown to extensively influence ion channel function (Lai and Jan, 2006). In this study, 
we have shown that Kv1.3 is enriched in the Golgi apparatus and that the degree of this 
enrichment is inversely correlated with the amount of channel in the plasma membrane.  
Removal of the C-terminal PDZ-binding motif of Kv1.3 decreases Golgi localization and 
increases channel at the cell surface. In turn, this decrease in Golgi localization is 
accompanied by an increase in Kv1.3 ionic current. We propose that retention of Kv1.3 
in the Golgi apparatus is a mechanism for regulating the amount of functional Kv1.3 
channels at the cell surface (Fig 6).   
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Biosynthetic trafficking is an important mechanism for determining the level of 
mature protein within a cell and can be regulated at multiple stages. Although several 
motifs exist for modulating the endoplasmic reticulum (ER) retention and export of 
potassium channels (Zarei et al., 2004; Zhu et al., 2005; Zhu et al., 2003a, b), the Golgi 
apparatus may also serve as a checkpoint for anterograde protein trafficking (Cheng et 
al., 2002; Gentzsch et al., 2003; He et al., 2002). We show that disrupting the PDZ-
binding motif of Kv1.3 significantly decreases the amount of Kv1.3 channel in the Golgi 
apparatus (Fig 4), suggesting that PDZ-mediated interactions may contribute to the 
regulated biosynthetic trafficking of this channel. Disrupting the PDZ-binding motif of 
Kv1.3 also increases the amount of channel at the cell surface and the amount of Kv1.3 
ionic current (Fig 5), supporting the idea that Golgi retention serves as a checkpoint for 
regulating Kv1.3 channel activity. The ∆TDV mutation increased surface expression of 
Kv1.3 by 60.0%, and increased Kv1.3 ionic current by 75.0%. These increases could 
result from a separate mechanism for regulating Kv1.3 channel at the plasma membrane. 
This is consistent with previous studies demonstrating that posttranslational modification 
of Kv1.3 can lead to alterations in Kv1.3 ionic current. For example, phosphorylation of 
Kv1.3 by cellular and receptor tyrosine kinases has been shown to induce current 
suppression of the channel (Bowlby et al., 1997; Colley et al., 2004; Fadool et al., 1997; 
Holmes et al., 1996; Marks and Fadool, 2007; Tucker and Fadool, 2002). In addition, 
protein interactions have also been shown to modulate Kv1.3 activity. Coexpression of 
the synaptic adaptor protein, PSD-95, significantly suppresses Kv1.3 peak current 
magnitude in a use-dependent fashion (Marks and Fadool, 2007). Therefore, separate 
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mechanisms of Kv1.3 channel modulation at the plasma membrane may alter the function 
of the channel without affecting surface expression.   
The notion that Kv1.3 Golgi localization serves as a checkpoint for regulating 
Kv1.3 function is also consistent with our observation that Kv1.3 Golgi localization is 
variable in HEK293 cells (Fig 1). The reason for this cell to cell variability is currently 
not known, however it could result from differences in steady-state signaling profiles 
between cells, resulting in altered effects on PDZ interactions. Many class I PDZ-binding 
motifs (X-S/T-X-Φ) are susceptible to posttranslational modifications that may alter the 
interaction of these motifs with PDZ domain containing proteins (Arnold and Clapham, 
1999; Ikenoue et al., 2008; Lin et al., 2006; Matsuda et al., 1999). For example, 
phosphorylation of these motifs via specific serine/threonine kinases has been shown to 
perturb protein-protein interactions. Phosphorylation of AMPA receptor GluR2 subunits 
by PKC can reduce the receptor binding affinity for GRIP, a synaptic PDZ domain-
containing protein (Matsuda et al., 1999). Similarly, casein kinase II can phosphorylate 
the NR2B subunit of NMDA receptors and disrupt the interaction of NR2B with both 
PSD-95 and SAP102, in turn decreasing surface expression of this receptor (Lin et al., 
2006).  Alternatively, acetylation of a lysine residue present in the PDZ-binding motif of 
PTEN has been shown to play a role in mediating PDZ domain interactions (Ikenoue et 
al., 2008). Therefore, posttranslational modification of the Kv1.3 PDZ-binding motif may 
alter protein-protein interactions and contribute to the observed variability of Kv1.3 Golgi 
localization in HEK293 cells.    
Other Kv1 family channels also contain similar PDZ-binding motifs, although the 
mechanisms of channel regulation differ considerably (Kim et al., 1995). We found that 
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Kv1.2, which also contains a C-terminal PDZ-binding motif, did not display the same 
degree of Golgi localization as Kv1.3 (Fig 1). These results are consistent with reports 
indicating that subcellular distribution of Kv1.2 is mainly in the endoplasmic reticulum 
(ER) and highlight a fundamental difference between two closely related channels of the 
same family (Shi and Trimmer, 1999). These differences in intracellular distribution may 
reflect differences in the various trafficking pathways involved in channel regulation. For 
instance, cyclic AMP-mediated increases in plasma membrane Kv1.2 have been shown to 
be independent of Golgi trafficking (Connors et al., 2008); Modulated endocytosis at the 
plasma membrane is a major determinant of Kv1.2 activity at the cell surface (Nesti et al., 
2004). In contrast to Kv1.2, our data suggest that the Golgi apparatus may function as a 
reservoir for Kv1.3 channel regulation. Overall, our findings suggest an additional, 
trafficking dependent mechanism for regulating Kv1.3 function in the cell, which exists 
in parallel with other mechanisms of channel regulation.  
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Figure Legends 
 
 
Figure 1: Intracellular distribution of Kv1.3. A) Vertical scatter plot depicting the 
mean Golgi localization (%) and distribution of both GFP-Kv1.3 (n = 20; mean = 28.5% 
± 3.1) and GFP-Kv1.2 (n = 20; mean = 12.6 % ± 0.85) transfected HEK293 cells. GFP-
Kv1.2 Golgi localization is significantly decreased compared to GFP-Kv1.3 (p <0.0001, 
Mann-Whitney test) B) Representative photomicrographs of HEK293 cells transfected 
with GFP-Kv1.3 (green) demonstrate a differential intracellular distribution of the 
channel. Each photomicrograph is an example of a cell in the range above (46.0%) and 
below (9.6%) the mean GFP-Kv1.3 Golgi localization. B) Representative 
photomicrograph of an HEK293 cell transfected with GFP-Kv1.2 (green) demonstrates a 
decreased percentage of this channel (13.0%) detected in the Golgi region. The GM130 
marker (red) was used to define the Golgi region. Scale bar = 10 μm. 
 
Figure 2: Kv1.3 surface expression is inversely related to Golgi localization of the 
channel.   A) Steady-state current-voltage relationships for GFP-Kv1.3 (open symbols) 
and GFP-Kv1.3-Flag (closed symbols) indicate no difference in channel function due to 
the presence of the extracellular Flag epitope. B) Activation curves plotted from the tail 
current of GFP-Kv1.3 (open symbols) and GFP-Kv1.3-Flag (closed symbols) indicate no 
difference in voltage sensitivity due to the presence of the extracellular Flag epitope. C) 
Representative photomicrograph of an HEK293 cell transfected with GFP-Kv1.3-Flag 
(green) and live labeled with anti-Flag-M2 (blue) to detect the extracellular Kv1.3-Flag 
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epitope, and thus Kv1.3 at the cell surface. After fixation, cells were labeled with anti-
GM130 (red) to define the Golgi region and to subsequently calculate Golgi localization 
(GFP-Kv1.3 in Golgi region / Total GFP-Kv1.3). D) Scatter plot depicting the 
relationship between Kv1.3 surface expression and Golgi localization for GFP-Kv1.3-
Flag. Linear regression analysis indicates that Kv1.3 surface expression is inversely 
correlated with Golgi localization of the channel (n = 82; R-squared = 0.56). E) 
Normalized surface expression of GFP-Kv1.3-Flag transfected HEK293 cells. Kv1.3 was 
binned into categories based on Golgi localization above (high; black bar) or below (low; 
white bar) the mean value (21.7%). Surface expression was calculated (anti-Flag-M2 / 
total GFP-Kv1.3-Flag) and both the high and low Golgi values were normalized to the 
mean value for cells exhibiting high GFP-Kv1.3-Flag Golgi localization. Surface 
expression of the low Golgi localized GFP-Kv1.3 population (n = 54; mean = 2.2 ± 0.12) 
is significantly higher than surface expression of the high Golgi localized GFP-Kv1.3 
population (n = 28; mean = 1.0 ± 0.10; p < 0.0001; unpaired t-test). Scale bar = 10 μm .  
 
Figure 3: Kv1.3 ionic current is inversely related to Golgi localization of the 
channel. Ionic current evoked by stepped voltages from -70 to + 50 mV in GFP-Kv1.3 
transfected HEK293 visually categorized as having A) high or B) low Golgi localization. 
Visual categorization was confirmed by blind assessment of Golgi localization, yielding 
zero false low Golgi localized channels. Current traces are averages of currents from 
multiple cells (n ≥ 12). C) Steady-state current-voltage relationships for GFP-Kv1.3 in 
cells categorized as having high (closed symbols) or low (open symbols) Golgi 
localization. Ionic current was significantly greater in cells categorized as having low 
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Kv1.3 Golgi localization. (*P ≤ 0.05; unpaired t-test).  D) Activation curves plotted from 
the tail current indicate no difference in channel voltage sensitivity in cells categorized as 
having high (closed symbols) and low (closed symbols) Kv1.3 Golgi localization.  
 
Figure 4: Disrupting the C-terminal PDZ binding motif of Kv1.3 decreases Golgi 
localization of the channel. A) Representative immunoblots and corresponding 
normalized immunodensitometry demonstrating no significant difference in protein 
expression of GFP-Kv1.3-WT (WT; mean = 1.0 ± 0.08) and GFP-Kv1.3-∆TDV (∆TDV; 
mean = 0.92 ± 0.14) in cells transfected with equal amounts of plasmid DNA (n = 8; p > 
0.05). GAPDH indicates equal loading between lanes and was used to normalize Kv1.3 
band intensities. B) Immunoblot of eluant from an in vitro maltose binding protein 
(MBP) pulldown assay of lysates from HEK 293 cells transiently transfected with myc-
PSD-95. Protein was collected with beads coated with either an MBP only control, MBP 
fused to the C-terminus of Kv1.3-WT (WT) or Kv1.3-∆TDV (∆TDV). Blots were probed 
with anti-Myc antibody (top) or anti-Kv1.3 C-term antibody (bottom). Removal of the 
PDZ binding motif of Kv1.3 abolishes the channels ability to pull down the canonical 
PDZ domain protein, PSD-95.  C) Representative photomicrograph of an HEK293 cell 
transfected with GFP-Kv1.3-∆TDV (green) and labeled with the Golgi apparatus marker, 
GM130 (red; n = 20). D) Vertical scatter plot depicting the Golgi localization (%) and 
distribution of GFP-Kv1.3 (WT) and GFP-Kv1.3-∆TDV (∆TDV) expressed in HEK293 
cells. For the purpose of comparison, the GFP-Kv1.3 (WT) data from Figure 1A is 
shown. The ∆TDV truncation (n = 20; mean = 11.1 ± 1.39) significantly decreased Kv1.3 
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Golgi localization compared to WT channel (n = 20; mean = 28.5% ± 3.1; Mann-Whitney 
test; p < .0001). Scale bar = 10μm 
 
Figure 5: Disrupting the C-terminal PDZ binding motif of Kv1.3 increases ionic 
current and plasma membrane expression of the channel. Ionic current measured in 
HEK 293 cells transfected with GFP-Kv1.3-Flag-WT and visually categorized as having 
A) high or B) low Kv1.3 Golgi localization.  C) Ionic current measured in HEK 293 cells 
transfected with GFP-Kv1.3-Flag-∆TDV (∆TDV). Current traces for each condition are 
the average of currents from multiple cells (n ≥ 15). D) Steady-state current-voltage 
relationships for GFP-Kv1.3-Flag-WT exhibiting high (open diamonds; n = 15; mean = 
9.2 mV ± 0.8) and low (open triangles; n = 15; mean = 15.5 mV ± 0.8) Golgi localization, 
as well as GFP-Kv1.3-Flag-∆TDV (closed squares; n = 27; mean = 16.1 mV ± 1.0) 
demonstrate a significant difference between WT high Golgi and ∆TDV (P ≤ 0.02; 
unpaired t-test). No difference in ionic current was detected between WT low Golgi and 
∆TDV. E) Activation curves plotted from the tail current indicate no difference in 
channel voltage sensitivity in cells expressing GFP-Kv1.3-Flag-WT exhibiting high 
(open squares) and low (open triangles) Golgi localization and GFP-Kv1.3-Flag-∆TDV 
(closed squares). F) GFP-Kv1.3-Flag surface expression in cells categorized as having 
high (n = 28; mean = 1.0 ± 0.10) or low (n = 54; mean = 2.2 ± 0.12) Golgi localization, 
compared to surface expression of GFP-Kv1.3-∆TDV (∆TDV; n = 59; mean = 1.6 ± 
0.11).  ∆TDV surface expression is significantly higher than surface expression of the 
WT high Golgi localized population (p < 0.0001). 
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Figure 6: Proposed model for Kv1.3 regulation. As Golgi localization of Kv1.3 
increases, both surface expression and ionic current decrease, a trend potentially 
mediated by the C-terminal PDZ-binding motif of the channel. Conversely, as Kv1.3 
Golgi localization decreases, both surface expression and ionic current increase, 
suggesting increased channel activity at the cell surface in response to disrupting the 
PDZ-binding motif.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
120
 
Figure 1: Intracellular distribution of Kv1.3. 
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Figure 2: Kv1.3 surface expression is inversely related to Golgi localization of the 
channel. 
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Figure 3: Kv1.3 ionic current is inversely related to Golgi localization of the 
channel. 
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Figure 4: Disrupting the C-terminal PDZ binding motif of Kv1.3 decreases Golgi 
localization of the channel. 
 
 
 
 
124
 
 
 
 
 
 
Figure 5: Disrupting the C-terminal PDZ binding motif of Kv1.3 increases ionic 
current and plasma membrane expression of the channel. 
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Figure 6: Proposed model for Kv1.3 regulation. 
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CHAPTER 4: COMPREHENSIVE DISCUSSION 
 
 Ion channels are key determinants of excitability in multiple cell types, including 
neurons (Schauf and Bullock, 1979). The localization of these ion channels to distinct 
cellular compartments greatly influences various components of neuronal function such 
as resting membrane potential, action potential characteristics and neurotransmission 
(Chiu and Ritchie, 1981; Lai and Jan, 2006; Rasband et al., 1998). Thus, understanding 
the regulatory mechanisms governing ion channel localization can provide fundamental 
insight into human physiology.  The main goal of this dissertation was to elucidate the 
localization, function, and regulation of the voltage-gated potassium channel, Kv1.3. The 
experiments outlined in Chapter 2 of this study reveal the novel role of Kv1.3 as a 
determinant of sympathetic neuronal activity. In addition to plasma membrane 
expression, Kv1.3 also exhibited intracellular localization to the Golgi apparatus in these 
neurons. Using a model cell system, the data presented in Chapter 3 reveal a role for the 
PDZ-binding motif in mediating this Golgi localization of Kv1.3. Collectively, this 
research emphasizes how channel localization can influence the functional importance of 
Kv1.3 and suggests a new mechanism of channel regulation.  
In Chapter 2, we used neurons from the sympathetic branch of the autonomic 
nervous system as a model to study endogenous Kv1.3. Previous research showed that 
Kv1 channel mRNA was present in superior cervical ganglia (Dixon and McKinnon 
1996). In addition, previous reports demonstrated that using 4-aminopyridine to block 
Kv1 family channels in postganglionic sympathetic neurons increased neurotransmitter 
release (Ikushima et al., 1981; Uhrenholt and Nedergaard, 2003). However, the specific 
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ion channels involved remained largely unexplored. We found that sympathetic neurons 
express Kv1.3 protein and that the channel is localized to both the soma and processes 
(Chapter 2, Figure 1).  Kv1.3 ionic current was also pharmacologically isolated from the 
soma, indicating that the channel is a determinant of the electrophysiological properties 
of these cells (Chapter 2, Figure 4). Extensive work in T lymphocytes has identified 
Kv1.3 as a major determinant in the regulation of resting membrane potential (Deutsch 
and Chen, 1993; Koo et al., 1997; Lin et al., 1993; Mello de Queiroz et al., 2008). 
Through mechanisms involving membrane depolarization and the subsequent attenuation 
of Ca+2 influx, selective Kv1.3 blockade suppresses the signaling cascades that lead to T 
lymphocyte activation and proliferation (Koo et al., 1997; Lin et al., 1993).  In this study, 
we show that Kv1.3 also influences the resting membrane potential and function of 
postganglionic sympathetic neurons; inhibition of the channel depolarizes resting 
membrane potential, decreases the latency to action potential firing, and increases 
nicotinic agonist-induced neurotransmitter release (Chapter 2, Figures 5 and 7).  
The research presented in Chapter 2 is the first demonstration that Kv1.3 
contributes to sympathetic neuronal function and provides evidence that regulating Kv1.3 
conductance can modulate neuronal excitability. Muscarinic acetylcholine receptor 
(mAChR) activation has previously been shown to suppress other K+ channels, namely 
Kv1.2 (Huang et al., 1993; Lechner et al., 2003). Initial studies exploring Kv1.2 
regulation found that mAChR activation led to suppression of the channel’s ionic current 
(Huang et al., 1993). The primary preganglionic input to postganglionic neurons is 
acetylcholine (ACh) and our studies present novel evidence that Kv1.3 current can also 
be modulated through mAChR activation (Chapter 2, Figure 6). Although tyrosine 
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phosphorylation-induced endocytosis has been defined as the mechanism for Kv1.2 
current suppression (Huang et al., 1993), and Kv1.3 ionic current is also known to be 
modulated via tyrosine phosphorylation (Holmes et al., 1996) , no direct evidence exists 
to link mAChR activation to Kv1.3 trafficking events. Further studies may aim to 
elucidate the mechanism of stimulus-induced Kv1.3 current suppression to determine 
whether this phenomenon is dependent upon altered channel biophysics, potentially 
resulting from conformational changes within the channel itself, or due to negative 
trafficking of the channel away from the plasma membrane.  
 The unusual observation that Kv1.3 exhibits localization to a discrete 
intracellular compartment (Chapter 2, Figures 2 and 3) led to the hypothesis that retention 
of this channel in the Golgi apparatus may constitute a trafficking-dependent mechanism 
of regulation. While it is known that Kv1.3 undergoes tyrosine phosphorylation-induced 
current suppression at the plasma membrane (Holmes et al., 1996), no evidence exists 
linking decreased current to trafficking events such as endocytosis. Therefore, exploring 
the intracellular localization of Kv1.3 may provide evidence for an additional, 
trafficking-dependent mechanism of channel regulation which may operate concurrently 
with the biophysical regulation observed in other studies.  Although similar intracellular 
localization of Kv1.3 has been previously reported in other cell types such as the 
HEK293 model cell system (Vicente et al., 2008a) and pyramidal neurons (Guan et al., 
2006), the work outlined in Chapter 3 is the first to quantify this Kv1.3 Golgi 
localization. In addition, this study proposes a novel mechanism of channel regulation 
that is PDZ-binding motif dependent. The third chapter of this dissertation is dedicated to 
elucidating the role of Kv1.3 Golgi localization in channel function at the cell surface. 
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We show that Kv1.3 channels expressed in HEK293 cells localize to the Golgi apparatus 
with a high degree of variability (Chapter 3, Figure 1). Interestingly, the degree of this 
Golgi localization is inversely correlated with surface expression of the channel, 
suggesting the Golgi apparatus may serve as a checkpoint for the regulated trafficking of 
Kv1.3 to the plasma membrane (Chapter 3, Figure 2).   
Previous work indicates that other ion channels are also localized to the Golgi 
apparatus (Cheng et al., 2002; Gentzsch et al., 2003). CFTR exhibits intracellular 
accumulation in the Golgi where it associates with a Golgi resident PDZ domain protein 
presumed to tether CFTR to this organelle and potentially regulate the channels transit to 
the plasma membrane (Cheng et al., 2002). Another chloride channel, ClC-3B, also 
localizes to the Golgi and has been found to associate with the same Golgi resident PDZ 
domain proteins as CFTR (Gentzsch et al., 2003). These findings, coupled with the 
knowledge that PDZ interactions play a major role in the localization and function of 
many proteins (Sheng and Sala, 2001), led us to hypothesize that Golgi localization of 
Kv1.3 may depend on protein associations with the C-terminal PDZ-binding motif of the 
channel. Interestingly, disrupting the PDZ-binding motif of Kv1.3 eliminated the striking 
intracellular localization of the channel to the Golgi apparatus, without altering the total 
amount of Kv1.3 protein within the cell (Chapter 3, Figure 4). This decrease in Golgi 
localization was accompanied by an increase in Kv1.3 ionic current (Chapter 3, Figure 5), 
indicating a potential role for the PDZ-binding motif in such processes as the regulation 
of Golgi retention-mediated channel trafficking to the plasma membrane or stabilization 
of functional channels already at the cell surface.  Subsequent analysis also reveals an 
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increase in the number of channels at the cell surface (Chapter 3, Figure 5), providing 
evidence for a trafficking dependent mechanism of Kv1.3 channel regulation.  
One possible mechanism for regulating Kv1.3 Golgi localization may involve 
protein-protein interactions. In a native HEK23 cell system, endogenous proteins may 
interact with the C-terminal PDZ-binding motif of Kv1.3 to retain this channel in the 
Golgi. Deleting this motif may disrupt these protein interactions, leading to increased 
channels at the cell surface and increased Kv1.3 ionic current. Further investigation may 
identify associations with specific PDZ domain proteins and reveal a role for these 
interactions in the anterograde trafficking pathways of the channel. While other members 
of the Kv1 family also contain C-terminal PDZ binding-motifs, their specific primary 
amino acid sequence varies (Kim et al., 1995). Previous studies have defined a role for 
the amino acids upstream from the final C-terminal residue, termed P0, in the recognition 
and binding of PDZ domain containing proteins (Jelen et al., 2003; Sheng and Sala, 
2001). Other members of the Kv1 family contain either a glutamate or leucine residue at 
the upstream P-3 position, which may be involved in mediating the selectivity of PDZ 
interactions (Kim et al., 1995; Songyang et al., 1997). However, the P-3 position of Kv1.3 
is occupied by phenylalanine, a nonpolar hydrophobic residue containing a large benzyl 
side chain. Therefore, the distinct Golgi localization of Kv1.3 may be mediated by a PDZ 
domain protein interaction whose specificity is dependent on this residue. The differences 
in channel localization within the same family can be addressed with future experiments 
including mutational analysis of specific amino acids, as well as constructing chimeric 
channels exchanging C-terminal domains. Alternatively, similar PDZ domain proteins 
may bind to the C-terminal sequence of Kv1 family channels; however, variability at 
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other amino acid positions outside the PDZ-binding motif may alter interactions between 
the binding of accessory proteins of a larger complex.            
Our reports are consistent with recent work indicating that the PDZ domain 
protein, PSD-95, suppresses the peak current magnitude of Kv1.3 over the course of 
repeated stimulation (Marks and Fadool, 2007). However, Marks et al also report that a 
phosphorylation-independent mutation of critical residues in the PDZ-binding motif of 
Kv1.3 abolishes this PSD-95 induced activity-dependent current suppression. However,  
no change in outward current between wild-type Kv1.3 and this PDZ mutation was 
reported (Marks and Fadool, 2007). Because our study employs a truncated form of 
Kv1.3 that lacks the phosphorylation site in the PDZ-binding motif, further investigation 
may reveal a role for post translational modification of this motif in the modulation of 
channel function at the plasma membrane.  
The data presented in this dissertation indicate that disrupting the PDZ-binding 
motif of Kv1.3 abolishes the binding of the channel to the canonical PDZ domain protein, 
PSD-95, and suggest that disrupting this motif may also interfere with the binding of 
other PDZ domain containing proteins involved in channel regulation. Additionally, we 
demonstrate that disrupting the PDZ-binding domain of Kv1.3 also decreases the Golgi 
localization of the channel. Although specific PDZ protein interactions in the Golgi have 
yet to be identified for Kv1.3, future directions may be aimed at pinpointing associated 
PDZ proteins responsible for regulating trafficking of the channel at the level of this 
organelle. We speculate that disrupting the PDZ-binding motif of Kv1.3 would disrupt 
the association of the channel with these Golgi resident PDZ proteins, in turn disrupting 
the Golgi regulation of Kv1.3.  
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Anterograde trafficking of Kv1.3 from the Golgi apparatus to the cell surface may 
be a regulated process, introducing the possibility that localization of Kv1.3 to this 
organelle may serve as a reservoir of readily releasable channel.  Posttranslational 
modification of PDZ binding-motifs has been shown to mediate their interaction with 
PDZ domain containing proteins (Chung et al., 2004; Matsuda et al., 1999). Therefore, 
serine/threonine phosphorylation of the Kv1.3 PDZ binding motif may be a mechanism 
for altering protein-protein interactions, in turn regulating the affinity of the channel for 
Golgi resident PDZ domain proteins. Decreased binding of Kv1.3 to Golgi associated 
PDZ proteins may lead to the regulated release of the channel from this compartment, 
increasing the amount of channel available for plasma membrane targeting. Similar to the 
phosphorylation-mediated disruption of protein interactions, the PDZ-binding motif 
deletion described in this dissertation may also eliminate the binding of Kv1.3 to specific 
Golgi resident PDZ proteins.  
Neurons contain compartmentalized structures such as the soma, axons, dendrites 
and presynaptic terminals (Dotti et al., 1988), components not present in HEK293 cells. 
The later portion of this study uses HEK293 cells to explore the relationship between 
intracellular Golgi localization of Kv1.3 and surface expression of the channel, however, 
these cells can only be used to study channel trafficking to and from a 
noncompartmentalized plasma membrane. A major determinant of neuronal function is 
the localization and distribution of ion channels along neuronal processes (Chiu and 
Ritchie, 1981; Lai and Jan, 2006; Rasband et al., 1998). Therefore, it is important not 
only to consider the regulation of plasma membrane expression of Kv1.3, but also how 
the spatial distribution of this channel can be modulated. Chapter 1 demonstrates that 
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endogenous Kv1.3 in postganglionic sympathetic neurons is enriched in the Golgi 
apparatus. Depending on the plasma membrane targeting of Kv1.3, regulated release of 
this channel from the Golgi may have differential effects on cellular function. Increased 
Kv1.3 in the somal plasma membrane compartment may lead to a hyperpolarization of 
resting membrane potential. Alternatively, an increase in the number of channels targeted 
to the axonal region may result in a faster rate of action potential repolarization. 
Ultimately, the trafficking of Kv1.3 from the Golgi apparatus to various plasma 
membrane compartments may decrease neuronal firing, shorten action potential duration 
and attenuate neurotransmitter release from these cells. Because altering the distribution 
of Kv1.3 in the neuronal membrane can have such widespread affects on neuronal 
function, it is important to gain a broader understanding of the regulation of these 
channels.   
The experiments presented in this dissertation have several limitations. Although 
HEK293 cells are a commonly used heterologous expression system for studying the 
biophysical properties and trafficking pathways of cloned ion channels (Connors et al., 
2008; Marks and Fadool, 2007; Nesti et al., 2004; Vicente et al., 2008b), observations 
made in this cell line require further investigation in more physiologically relevant 
systems.  It is important to note that the conclusions in Chapter 3 of this study are based 
on data collected from exogenous ion channel expression in HEK293 cells. Although this 
work has established a foundation for understanding the effect of localization on Kv1.3 
function, future directions include manipulating endogenous Kv1.3 in primary neuronal 
cell culture. In vitro neuronal manipulations, such as disrupting Kv1.3 protein-protein 
interactions or RNA interference of endogenous channels, may provide insight into how 
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these channels and their associations affect neuronal function is a more physiologically 
relevant system. Furthermore, the present studies measure [H3]-norepinephrine release 
from exogenously loaded neurons in cell culture in response to nAChR stimulation in the 
presence of a Kv1.3 inhibitor. The dissociated neurons used in this method have been 
subject to multiple enzymatic treatments which have altered them from their native state 
and extracellular environment.  The dissociation processes strips the neurons of their 
axons and dendrites, therefore any neurite outgrowth in culture may have physiological 
characteristics different from in vivo preparations. Furthermore, experimental 
manipulation of exongenously loading these cultured cells with [H3]-norepinephrine may 
have altered the physiological stores of endogenous norepinephrine, potentially 
contributing to experimental error.  While [H3]-norepinephrine release in this study is 
measured as a percentage of total radiotracer loading, it is important to note that the 
amount of exogenously introduced neurotransmitter may reflect more than the 
endogenous norepinephrine stores, thereby creating a larger pool from which an 
amplified release may be observed. Alternatively, this technique may be limited by cell to 
cell variability in the rate and efficiency of neurotransmitter uptake, attenuating the 
observed norepinephrine release in response to nAChR activation.  
Because sympathetic neurons communicate with target tissues such as blood 
vessels via the release of this neurotransmitter (Bennett et al., 2004; McLachlan, 2007), 
measuring the change in circulating plasma norepinephrine in response to Kv1.3 
inhibition in the intact animal can provide valuable information regarding the role these 
channels play in overall sympathetic function without introducing artificial 
neurotransmitters. In addition, determining the direct effects of Kv1.3 blockade on 
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arterial diameter and blood flow can provide greater insight into the role these channels 
play in vivo. Furthermore, this study does not incorporate pharmacological agents to 
disrupt Kv1.3 trafficking. Therefore, the complimentary approach of using protein 
transport or microtubule assembly inhibitors for studying the effect of localization on ion 
channel function would further aid in elucidating the mechanisms involved in Kv1.3 
regulation.   
An additional limitation of this study is the use of the venom-derived toxin, 
MgTX, to inhibit Kv1.3. While the specificity of channel inhibition is dependent on toxin 
concentration, discrepancies exist in defining this optimal range. An alternative approach 
to inhibiting endogenous Kv1.3 with MgTX is incorporating an antisense strategy such as 
RNA interference to eliminate Kv1.3 protein production within cultured cells. In terms of 
future studies, MgTX application in vivo may not be an effective approach due to the 
instability of peptide application in a living animal, as well as the inability to specifically 
administer the peptide to select regions. For this reason, directed gene knockdown may 
provide a more thorough understanding of the effects of chronically eliminating Kv1.3.  
In summary, the work presented in this dissertation is the first to identify the 
Kv1.3 voltage-gated potassium channel as a key determinant of sympathetic neuronal 
activity. Initial studies sought to characterize the expression and function of Kv1.3 in 
these neurons and in the process, revealed a novel pattern intracellular localization to the 
Golgi apparatus. This work has identified a role for the PDZ-binding motif in mediating 
Golgi localization, surface expression and function of Kv1.3, leading us to propose that 
the regulated subcellular distribution of the channel is a determinant of Kv1.3 function. 
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